Full Report

Industry — Private Markets Asset Management

Partners Group sells access to private markets — investments in companies, real estate, infrastructure, debt and royalties that are not listed on a public exchange. Its customers are pension funds, insurers, sovereign wealth funds and (increasingly) wealthy individuals who pay a recurring management fee on assets under management (AuM) plus a performance fee (also called carried interest) on realised gains. Money flows in for years, gets locked up for years, and only comes out as the manager exits portfolio assets. The industry's economics rest on three things most newcomers underestimate: long-duration fee streams, balance-sheet light operating leverage, and the slow, lumpy translation of unrealised marks into cash.

Global private markets AuM stood at roughly USD 20.3 trillion in early 2026 and is forecast to reach USD 26.7 trillion by 2030 (PitchBook, 2030 Private Market Horizons, May 2026). Within that, real assets (infrastructure + real estate) and private credit are growing fastest; traditional buyout fundraising has been weak since 2022 as higher rates ended the era of cheap leverage.

1. Industry in One Page

The GP sits in the middle and earns the deepest profit pool because it controls both the capital-raising relationship and the underlying asset operations. That dual control is why EBITDA margins in this industry routinely run above 50 % — far above any traditional asset manager. The other thing newcomers misunderstand: private-markets AuM is sticky in a way mutual-fund AuM is not. A traditional closed-end fund's capital is contractually committed for ~10 years; investors cannot redeem. Even evergreen (open-ended) products gate redemptions to roughly 5 % per quarter. A private-markets manager can keep earning fees through a market downturn while traditional managers see outflows the same week.

2. How This Industry Makes Money

The revenue engine has two layers. Management fees are recurring, contractual, asset-based — a percentage of AuM (or invested capital) charged annually regardless of performance. Performance fees (carried interest) are a share of realised gains above a minimum return ("hurdle rate", typically 8 %), paid only when the manager exits assets. Layer one is the bond; layer two is the equity.

The cost structure is fixed, human-capital heavy, and operationally light: ~80 % of operating cost is people. There is no factory, no inventory, very little working capital. That gives the model unusual operating leverage. PGHN reports a stable ~63 % EBITDA margin for seven straight years and tells investors that newly generated management fees and performance fees come in at a ~60 % incremental operating margin (CMD March 2026, p. 35-36). Up to 40 % of newly generated performance fees are channelled directly back to employees as variable comp, which protects the margin during exit droughts.

Where bargaining power sits. Largest LPs (sovereign wealth, top pension funds) extract fee discounts and bespoke economics. Smaller LPs and private-wealth retail pay the rack rate. That is why PGHN's bespoke mandate book — at 33 % of AuM — looks more like an institutional service business than a fund factory, while its evergreen book — 37 % of AuM — looks more like a mass-affluent product business. Each has a different fee economic and a different liquidity profile (see §3).

3. Demand, Supply, and the Cycle

Demand has three drivers stacked on top of each other:

1. Allocation shift. Pension funds, insurers and sovereigns have increased target allocations to private markets from low single digits twenty years ago to ~20-25 % today, because public markets cannot absorb their capital and offer thinner expected returns net of inflation.
2. Wealth democratisation. The newly addressable pool is the global private-wealth client (~USD 80 - 100 trillion of investable assets), historically excluded from private markets by ten-year lock-ups. Evergreen and semi-liquid fund structures — which PGHN pioneered — solve the lock-up problem and are the single fastest-growing distribution channel. Blackstone reported private-wealth fundraising of USD 43 bn in 2025 (+53 % YoY); EQT reports 26 % of fundraising came through private wealth in 2024-25.
3. Real-asset tailwinds. Energy transition (EUR 8 trn cited investment need), data-centre/AI infrastructure, and decarbonisation create idiosyncratic demand for infrastructure capital that is largely insensitive to the public-equity cycle.

The 2022-2024 cycle was unusual: rising rates ended multiple expansion as a return source, fundraising fell ~30 %, exit windows shut, and DPI (cash returned to LPs) collapsed. That created the liquidity-deficit trade of 2024-25: LPs sold fund stakes into the secondary market, which hit a record USD 240 bn of volume in 2025 (+48 % YoY, Jefferies Global Secondary Market Review, January 2026). Continuation vehicles >USD 1 bn rose 57 % YoY.

A 2026 risk worth watching: as evergreen products scale, redemption stress can replace fundraising stress as the leading indicator of trouble. Steffen Meister (PGHN executive chair) told the FT in April 2026: "If we see redemptions in these amounts above the gates, we will gate." Industry gates typically activate at 5 % quarterly redemption thresholds.

4. Competitive Structure

The industry is fragmented at the long tail but highly concentrated at the top. A handful of platforms manage close to half of all institutional commitments; thousands of single-strategy GPs compete for the rest. The pyramid is widening: the top firms are growing share by adding asset classes (PE → infra → credit → secondaries → wealth) faster than independents can match. Ares reported a record USD 30 bn of Q1 2026 fundraising alone (Hedgeco, May 2026); Apollo crossed USD 1 trillion AuM in early 2026.

Two structural points:

• Scale begets scale. LP allocations are concentrating into the top 10-15 platforms because these firms can offer cross-asset bespoke mandates, separately managed accounts, and credible co-investment pipelines. Single-strategy GPs are increasingly forced to choose between selling a GP stake, merging, or shrinking. Private Equity International reports record-level GP-on-GP M&A in 2025.
• Wealth distribution is the new battleground. The race is not really about asset management capability; it is about who owns the distribution rails into private banks, RIAs and 401(k) plans. JV ecosystems matter — PGHN signed JVs in 2025 with Deutsche Bank (evergreen launch), PGIM (multi-asset portfolios) and Generali (credit secondaries).

5. Regulation, Technology, and Rules of the Game

Regulation is currently expansionary in the United States and tightening on liquidity in Europe, with two specific 2025-26 catalysts that materially change the addressable market.

Technology shifts to track:

• Tokenisation and on-chain fund administration are early but real. BlackRock, Apollo and others are running tokenised fund pilots; this could reduce administration cost and speed up capital calls/distributions over a 5-10 year horizon.
• AI inside portfolio companies. Top managers are now positioning value creation around AI-driven margin and growth uplift inside owned portfolio companies, not just sourcing edge. PGHN management cited ~35 % of direct portfolio companies adopting at least one AI initiative vs ~9 % for the broader large-firm benchmark (CMD 2026, p. 31).
• Data and platform integration. Operating systems for portfolio steering (PGHN's Value Navigator, Blackstone's BX Build) increasingly differentiate the integrated platforms from sub-scale rivals.

6. The Metrics Professionals Watch

Forget the off-the-shelf bank ratios. The metrics that move private-markets stock prices are about AuM dynamics, fee quality, and exit cadence.

A useful sanity check: in private markets, accounting earnings can over- or under-state fee-related earnings (FRE) because performance fees are episodic and investment income is mark-to-market. The most disciplined investors look at fee-related earnings (management fees minus mgmt-fee-funded costs) separately from realised performance income, and discount them at different multiples — typically 18-25× for FRE versus 8-12× for carried interest.

7. Where Partners Group Holding AG Fits

PGHN is a mid-sized, integrated, global private-markets manager with a clear positioning that does not fit the dominant US-megaplatform mould. It is smaller than Blackstone, Apollo, Brookfield or KKR by AuM, but ahead of most pure-PE European peers. Its differentiation rests on two structural choices: an integrated, cross-asset thematic platform (no siloed fund teams) and a bespoke-solutions distribution model with mandates and evergreens collectively at 67 % of AuM.

PGHN's CMD 2026 base case targets USD 450 bn AuM by 2033, implying a ~13 % CAGR — below the megaplatforms' aspirational targets but consistent with industry forecasts of bespoke-solutions growth (Morgan Stanley/McKinsey: bespoke pool USD 2-5 trn → 6-8 trn by 2033).

A note on what is not settled: a March-April 2026 short-seller report (Grizzly Reports) and FT coverage of evergreen liquidity raise questions about valuation marks and redemption risk in PGHN's Master Fund. Those are addressed in the business and bull/bear tabs — but a reader should not assume "industry leader" implies "uncontested franchise."

8. What to Watch First

Five-to-seven signals that quickly tell you if the industry backdrop is improving or deteriorating for PGHN, in order of leading-indicator power:

1. Quarterly gross client demand (PGHN trading updates). 2026 guidance: USD 26-32 bn. Tracking above USD 8 bn quarter-run-rate is bullish; falling below USD 6 bn signals fundraising stress. Q1 2026 came in at USD 8.3 bn — annualised at the upper end of guidance.
2. Industry secondaries volume vs. realisations (Jefferies semi-annual review). Strong secondaries volume + weak primary realisations is a liquidity stress signal for the whole industry; both rising together is healthy.
3. Evergreen redemption flows — PGHN, Blackstone, Apollo, Blue Owl. Net inflows continuing means private-wealth distribution still works; gates being triggered anywhere in the peer group is a red flag for sentiment.
4. Performance-fee guidance cadence. PGHN guides 25-40 % of revenue through the cycle. Persistent results in the lower half (as in 2026 guidance) signal exit-cycle delay; upper half signals a healthy DPI environment.
5. Management fee margin trend (annual report APM definitions). PGHN historical band 1.18-1.33 %; readings near or below 1.18 % indicate continued client-mix shift and fee compression — manageable but material.
6. US 401(k) DC roll-out concrete adoptions. Watch for first major-record-keeper add of a private-markets target-date or model-portfolio sleeve (Empower, Fidelity, Voya, Vanguard). This is the binary catalyst for PGHN's biggest TAM expansion.
7. CHF/USD and CHF/EUR. PGHN earns revenue ~45 % USD / 45 % EUR but reports in CHF. A 5 % CHF appreciation cuts ~0.5 ppt off EBITDA margin (CMD 2026 p. 37). Unhedged FX is a small but real swing factor against reported numbers.

Know the Business — Partners Group Holding AG (PGHN)

Partners Group is a global private-markets manager that monetises one durable thing: the right to keep charging a recurring fee on USD 185bn of locked-up client capital across private equity, infrastructure, real estate, private credit and royalties. The market correctly understands the franchise is high-margin, asset-light and bespoke-skewed; it is currently arguing about whether the 25-40% performance-fee share is repeatable through the cycle, and whether the evergreen retail channel that drove 2024-25 inflows now carries embedded redemption risk. Bottom line: a fee-and-carry compounder with a 63% EBITDA margin and ~55% ROE, where the valuation work is the durability of management fees, the multiple to attach to lumpy carry, and how to underwrite the evergreen book separately from the institutional book.

1. How This Business Actually Works

The economic engine is a fee on locked capital that mostly cannot leave. Clients commit capital that is drawn down over years and locked for a decade or more in closed-end vehicles, or restricted to ~5% quarterly redemption gates in evergreens. Partners Group earns a recurring management fee of roughly 1.24% on average AuM (the 20-year band: 1.18-1.33%) plus a performance fee — typically 20% of realised gains above an 8% hurdle — when assets are exited. Costs are ~80% people; capex was CHF 8m on FY25 revenue of CHF 2,563m. That structure is what turns a 1.24% fee on AuM into a 63% EBITDA margin and a 55% ROE.

The cleanest way to see why margins are sticky is the 20-year management-fee margin chart: it has stayed in a narrow 1.18-1.33% range for two decades despite repeated waves of fee compression in public-market asset management. The reason is mix, not pricing power on a single product. Mandates and evergreens — which together are 67% of AuM — are not commoditised funds; they are bespoke, multi-asset, multi-year client architectures with switching costs measured in committee cycles and consultant relationships, not basis points.

The performance-fee layer is the optionality. Carried interest is realised when assets are exited and is contractually limited to 20% of gains above an 8% hurdle. Up to 40% of newly generated performance fees flow back to employees as variable compensation, which is why margins do not collapse when carry is light: roughly half the revenue volatility is absorbed by the bonus pool before it hits EBITDA. Performance fees were 32% of FY25 revenue, well above the 24% prior-year level and above PGHN's own 25-40% guided long-term band. Management has explicitly told the market 2026 will land at the lower end of that band because some 2026 carry was pulled into 2025.

The single counter-intuitive feature: revenue has more volatility than EBITDA. In 2022 revenue fell 29% year-on-year (CHF 2,629m to CHF 1,872m) but EBITDA only fell 31% and the EBITDA margin moved from 64.3% to 62.6%. That is the bonus-pool absorber at work and is the reason the model has a different cyclicality profile than its top-line suggests.

2. The Playing Field

Partners Group looks small next to the US megaplatforms but trades on multiples that imply it is a high-quality scaled franchise — and the comparison with European pure-play EQT is the more revealing one. Across peers, the differentiator is not AuM, it is what mix of fees the AuM produces, and how those fees translate into EBITDA after carry pay-outs.

Three takeaways from the table. PGHN earns the highest EBITDA margin of any disclosed peer at 62.8%, beating EQT (52.5%) and BX (50.5%) — a function of the 67% bespoke-mix, not scale. PGHN trades on the cheapest EV/EBITDA of the credible pure-play peers at 16.0× versus EQT at 26.0× and BX at 19.1×. ROE at 54.8% is the highest of the group — genuine economic returns multiplied by a ~95% dividend payout that keeps the equity base small.

The closest economic comparable is EQT, not Blackstone — both are European-listed pure-plays without insurance noise, both run integrated thematic platforms, both depend on bespoke and evergreen distribution. EQT trades at ~62% premium on EV/EBITDA despite a lower margin and lower ROE; the market is paying for EQT's stronger AuM growth, larger buyout franchise and higher private-wealth share. PGHN's discount reflects slower growth, Q4 2025 redemption noise around the evergreen book, and the March-April 2026 short-seller report on Master Fund valuation marks. The peer table tells you what the asset is worth in normal-state economics; the discount tells you what bears think those normal-state economics are worth.

3. Is This Business Cyclical?

This is a cyclical business, but not in the way newcomers expect. Management fees are remarkably stable; the cycle hits realisations, and realisations drive performance fees, investment income and (eventually) fundraising. The 2022 episode is the cleanest illustration: when buyout exits collapsed, performance fees more than halved and total revenue fell 29%, but management fees actually rose, and EBITDA margin barely moved.

The exit cycle, not the macro cycle, is the right frame. The 2022-2024 stretch had three things going wrong at once for the industry: rates rose, multiple-expansion as a return source ended, and IPO/M&A windows closed. PGHN's underlying portfolio mark-downs were modest, but performance fees fell hard and DPI to LPs slowed. By 2025 the exit window had reopened — direct realisations were up 54% YoY and infrastructure realisations up 491% YoY — and FY25 performance fees of CHF 819m landed in the upper half of the 25-40% guided revenue band. That is the rhythm to expect: a 2-3 year exit drought followed by a 1-2 year carry surge as mature vintages are realised. Anyone modeling smooth performance fees is wrong.

A new cycle variable to watch: redemptions in evergreens. In 2025 PGHN saw 11% annualised redemptions across its evergreen platform (concentrated in mature PE), with private-credit evergreens seeing >5x more inflows than outflows. Industry liquidity gates typically activate at 5% quarterly. Steffen Meister told the FT in April 2026 the firm "will gate" if redemptions exceed thresholds. Evergreen redemption stress is the new leading indicator that did not exist in prior cycles, and it is the variable behind much of the March-April 2026 share-price drawdown.

4. The Metrics That Actually Matter

Forget P/E and P/B in isolation; the question this business answers is whether AuM is growing, whether the fee on that AuM is holding, and whether realisations are producing carry. Five metrics frame the franchise.

Two metrics deserve emphasis. Gross client demand is the only forward indicator: it is what filters into management fees 12-24 months later. PGHN guided 2026 at USD 26-32bn, broadly flat-to-up versus 2025's USD 30bn. The Q1 2026 trading update came in at USD 8.3bn, annualising at the upper end. Performance-fee share of revenue matters not because it predicts the next quarter, but because it tells you how much of trailing earnings the market should discount differently. PGHN has guided 25-40% through the cycle; the right way to think about FY25's 32% is not as a run-rate but as a number that will mean-revert. The disconnect between earnings reported and earnings durable is precisely why this stock periodically reprices on results day even when the headline beats.

The mgmt-fee margin trend in chart §1 is the third metric most worth watching closely. It has drifted from 1.36% in 2017 to 1.24% in 2025 — a real but modest erosion, mostly mix shift to mandates and evergreens, both of which carry slightly lower headline rates than traditional closed-end funds but stronger client lock-in. Below 1.18% would be a meaningful regime change.

5. What Is This Business Worth?

The right valuation lens is fee-related earnings (FRE) at one multiple, performance fees and investment income at a lower one — sum to a single equity value. Consolidated P/E on this business mis-prices it because performance fees and investment income (the two volatile lines) get mechanically blended into trailing earnings; a "20× P/E" that includes a peak-cycle carry year overstates durable value, and the same 20× in a trough year understates it. Treat the two engines separately and the picture clarifies.

The arithmetic puts fair value in a roughly CHF 26-32bn equity-value band — broadly in line with the FY25-end market cap of CHF 25.3bn, and above the post-March-2026 drawdown level near CHF 21bn. The key judgement is what FRE multiple this franchise deserves. A conservative 18× (treating PGHN like a global asset manager facing fee compression) gives CHF 19bn for FRE alone; a premium 25× (treating it as a category-leader compounder with bespoke moats) gives CHF 26bn. A 7-point swing in the FRE multiple is worth more than the entire market cap of the carry book.

Conditions that would support a premium: continued sub-1.30% mgmt-fee margin stability, evergreen redemptions normalising to single-digit annualised, and progress toward the USD 450bn 2033 ambition. Conditions that would support a discount: a 5%+ quarterly evergreen gate event, mgmt-fee margin breaking below 1.18%, or any forensic finding that NAV marks are systematically optimistic. The ~37% multi-month drawdown into FY2025 results day shows the market is currently sensitive to all three; the variant question is whether that fear is fully priced.

6. What I'd Tell a Young Analyst

Three things to build a discipline around. First, separate FRE from carry every quarter — most sell-side notes blend them. Performance fees in any single year tell you almost nothing about durable earnings power; the mid-cycle 25-40% guide is the only useful frame, and any year outside that band is a temporary pull-forward or a temporary drought. Build a model where management-fee NPV and carry NPV are valued separately at different multiples; you will arrive at intrinsic value with less noise than the sell-side does.

Second, track gross client demand and mgmt-fee margin together, not AuM growth alone. Headline AuM growth was 21% in 2025 but only 14% organically — the difference was FX, performance, and mark effects. Strip those out, watch gross fundraising, and watch tail-down (the rate at which mature closed-end funds roll off). PGHN guides USD 26-32bn gross demand and USD 10-13bn tail-down in 2026; the net is what becomes fee-paying AuM.

Third, evergreen redemptions are now the most important leading indicator of trouble in this whole industry. The closed-end book is bond-like by construction; the evergreen book is not. Track quarterly evergreen redemption percentages and the ratio of inflows to outflows by asset class. In 2025 PGHN's evergreens saw 11% annualised redemptions concentrated in mature PE, but credit evergreens saw >5x more inflows than outflows. If that ratio inverts anywhere in the peer group — Blackstone's BREIT, Apollo's S-3, PGHN's Master Fund — sentiment on the entire sector reprices.

Competition — Partners Group Holding AG (PGHN)

Competitive Bottom Line

Partners Group has a real but narrow moat built on bespoke client architecture rather than scale. Inside its niche — institutional separate accounts and pioneered evergreen private-markets products that together account for 67% of AuM — it earns the highest EBITDA margin (62.8%) and the highest ROE (55%) in the listed alternative-asset peer group, well ahead of Blackstone (50%), EQT (52%), Apollo (26%) and Ares (20%). Outside that niche it is sub-scale: at USD 184.9bn AuM, PGHN is one-seventh the size of Blackstone and one-fifth of Apollo, and it has no insurance balance sheet to recycle permanent capital the way KKR's Global Atlantic and Apollo's Athene do. The single competitor that matters most is Blackstone — not as a buyout rival but as the firm whose private-wealth distribution machine (BREIT, BCRED, BXPE) sets the velocity benchmark for the evergreen channel that drove PGHN's 2024-25 inflows. If BX continues to capture that channel at multiples of PGHN's pace, the bespoke-margin advantage erodes through mix shift before any single client is lost.

The Right Peer Set

The five public alternative-asset managers below are direct economic substitutes: each runs a fee-related-earnings + carried-interest model on third-party private-markets capital, and each competes for the same institutional and private-wealth pools as PGHN. The Dan-staged peer set excluded Brookfield (real-asset-heavy, spinoff comp complexity), Carlyle (volatile carry pattern), and the smaller European peers Bridgepoint and 3i (sub-scale or balance-sheet-investing model). Inside the chosen five, two natural sub-groups emerge: pure-play fee-and-carry managers (BX, ARES, EQT, PGHN) and insurance-flywheel hybrids (KKR, APO).

Three takeaways from the peer set. Scale and value diverge in this industry: Blackstone is 5× PGHN by market cap but earns a lower EBITDA margin by 12 percentage points, because BX's mix carries more open-ended NAV-fee structures and a heavier private-wealth servicing cost base. EQT is the cleanest direct comp — same European pure-play structure, same thematic platform, same private-wealth angle — and trades at 26.0× EV/EBITDA versus PGHN's 16.0×, a 60% premium for stronger fundraising velocity, the pending Coller Capital combination, and a higher private-wealth share. APO and KKR are economically different animals: consolidated EBITDA margins (26% and ~4%) are not directly comparable because they include Athene/Global Atlantic insurance investment income; their fee-only "asset management" segments run closer to BX and PGHN, but the hybrid model itself is the differentiator.

Where The Company Wins

PGHN does four things measurably better than every public peer. None of them is "we are the biggest" — and that is the whole point of the franchise.

1. Highest EBITDA margin in the listed peer set, on a stable 20-year fee-rate band. Group EBITDA margin was 62.8% in FY2025 (CHF 1,611m EBITDA on CHF 2,563m revenue, per FY2025 results) and has held inside 62-65% for seven straight years. The reason is mix, not size. PGHN's management-fee margin (gross fees ÷ average AuM) has stayed inside a narrow 1.18-1.33% range every year from 2006 to 2025 despite waves of fee compression in public-market asset management — only EQT comes close on margin (52.5% group EBITDA), and EQT does it on a thematic-PE-heavy book that is more concentrated by strategy. Blackstone, the scale leader, runs at 50.5%; Ares at ~20% on a credit-heavy mix; Apollo at 26.4% on a consolidated basis distorted by Athene. Source: PGHN business tab; FY2025 income.json across peers.

2. Highest bespoke/evergreen share of AuM, which converts directly into pricing-power durability. PGHN reports 33% bespoke separate-account mandates + 37% evergreens = 67% non-commoditised AuM (CMD March 2026, p. 8). Bespoke mandates are committee-cycle decisions with consultant relationships and multi-year RFP processes — switching costs are measured in 18-24 month sales cycles, not basis points. Evergreens are the second moat: PGHN was the first manager to launch a PE 40-Act fund (US), the first to launch a PM ELTIF (Europe), and the first to launch a US PE DC CIT for retirement plans. The CMD 2026 deck notes "~30% semiliquid/evergreen" of AuM versus single-digit shares for most rivals. By contrast, BX and APO are catching up on retail evergreens but starting from large institutional drawdown books; EQT only crossed 26% wealth-share of fundraising in 2024-25 (per industry-research); KKR and ARES are still scaling.

3. Best-in-class ROE (54.8%), which is genuine economic returns x capital discipline. PGHN's ROE is multiples of BX (29.2%), APO (14.7%), ARES (13.5%), KKR (8.8%) and EQT (9.3%). Two-thirds of the difference is the asset-light fee-and-carry model with capex of CHF 8m on CHF 2,563m revenue in FY25; the remaining third is a ~95% dividend payout that keeps the equity base small. ROE this high in the absence of leverage, hedge-book gearing, or acquisition goodwill is unusual — it is the cleanest single number that proves the bespoke-architecture story is real, not story-telling. Source: business-claude tab; ratios.json across peers.

4. The most diversified asset-class platform among non-insurance peers. PGHN is the only listed pure-play that runs at meaningful scale across all five private-markets segments: PE 46%, credit 22%, infrastructure 19%, real estate 12%, plus royalties (the only listed peer with a sizeable royalties book). EQT lacks credit and royalties; ARES is credit-dominant (75%+); BX is RE/credit-led. The cross-asset reach is what enables the bespoke-mandate model — a single pension-fund client can give PGHN one ticket spanning four asset classes with bespoke pacing and bespoke fees, which neither pure-PE EQT nor credit-led ARES can match.

Where Competitors Are Better

Four areas where PGHN is genuinely behind, with the specific competitor that exposes the gap.

1. Distribution scale into private wealth — Blackstone is far ahead. BX raised USD 43bn from private wealth in 2025, +53% YoY, across BREIT, BCRED, BXPE, BXINFRA and BXPE-style vehicles (per industry-research and BX FY2025 10-K). PGHN does not break out absolute private-wealth fundraising by year, but its evergreen Master Fund is sub-USD 20bn AuM and its 2024-25 evergreen inflows (per CMD 2026) were a fraction of BX's pace. The implication is mix-shift risk: as private-wealth AuM dilutes the institutional-mandate base across the industry, the firms with bigger wealth-distribution rails (BX, APO via Apollo Wealth, eventually KKR via DC channels) capture disproportionately more of the next leg of growth. PGHN's three 2025 JV signings — Deutsche Bank for evergreen launch, PGIM for multi-asset, Generali for credit secondaries — are the right response, but they are partnerships, not owned distribution. Source: BX FY2025 10-K business section; industry-claude tab §3.

2. Insurance balance-sheet flywheel — APO and KKR have a structural fee-plus-spread advantage that PGHN cannot replicate. Apollo consolidates Athene and KKR consolidates Global Atlantic, two annuity insurers that produce permanent capital plus a spread-investment income stream. APO's consolidated revenue was USD 32.0bn in FY2025 versus PGHN's CHF 2.6bn — most of the gap is investment income from Athene, not fee revenue, but the structure is what allows APO to underwrite below-market direct origination, retain inflows during fundraising droughts, and grow AuM through accretive insurance M&A. PGHN has explicitly chosen not to acquire an insurance carrier (CFO commentary, FY2024 results) and instead positions its co-investment book (CHF 1.7bn alongside clients) as a skin-in-the-game model. That is a strategic choice with merits, but it means PGHN earns fees on a smaller permanent-capital pool than the hybrids do, and is more exposed to fundraising cycles.

3. Credit franchise depth — Apollo and Ares dominate direct lending. Apollo manages USD 749.2bn of credit AUM (10-K p. 14), of which USD 302.1bn is direct origination plus USD 282.7bn asset-backed finance. Ares' Credit Group manages USD 406.9bn AUM with USD 274.3bn in direct lending across US and Europe. PGHN's private-credit AuM is roughly USD 41bn (22% of CHF/USD-equivalent AuM at YE25, per CMD 2026). For LP clients building large multi-strategy private-credit allocations, PGHN is a participant rather than a destination — which limits its share of the fastest-growing segment of private markets (private credit grew ~21% CAGR 2020-25 versus PE ~9%). The 2025 Generali credit-secondaries JV is the right strategic answer, but it does not close the absolute scale gap with APO/ARES anywhere near term.

4. Fundraising velocity is materially behind US scale leaders. Ares reported USD 30bn of fundraising in Q1 2026 alone (Hedgeco, May 2026). Apollo crossed USD 1 trillion AuM in early 2026. BX added more than USD 100bn of net AuM in 2025 across all channels. PGHN guided FY2026 gross client demand at USD 26-32bn for the full year — meaning Ares' Q1 alone was roughly equal to PGHN's full-year ambition. Smaller absolute fundraising magnifies any single-client churn risk and slows AuM compounding. Q1 2026 PGHN fundraising came in at USD 8.3bn (annualised at upper end of guide), which is healthy on a relative basis but does not change the absolute scale gap.

These four gaps are correlated: smaller fundraising → smaller AuM growth → less leverage to drop incremental new-money fees onto a fixed cost base → harder to fund the marketing and seeding cost of new evergreen launches. The bull case requires the bespoke moat to widen faster than the scale gap closes against it.

Threat Map

The map below ranks the threats not by which competitor is biggest in absolute terms but by which one most directly compresses PGHN's specific fee or AuM base over the next 24 months.

The two threats that combine High severity + near-term horizon — private-wealth share capture and evergreen redemption stress — both run through the semiliquid retail-private-markets product line and both are the variables behind the March-April 2026 PGHN drawdown. The insurance-flywheel threat is structural and cannot be neutralised by execution: the industry's best competitive answer (build or buy an insurer) has been ruled out by PGHN management.

Moat Watchpoints

Five measurable signals an investor should watch each quarter to know whether PGHN's competitive position is improving or weakening. None of them are about Q-on-Q EPS noise; all are about the durable fee-and-mix engine.

Current Setup & Catalysts — Partners Group Holding AG (PGHN)

PGHN trades at CHF 879 because the market is still digesting the FY2025 results print on 10 March 2026 (close CHF 818, ~37% below late-2024 highs after a multi-month de-rating) — not because the franchise has broken, and not because anything has been resolved. The print bundled two unrelated negatives — an EPS miss and the first explicit management-fee guide-down of the Layton era — and was followed seven weeks later by a Grizzly Research short report alleging Master Fund NAV mismarks. The next four reporting cycles between 20 May 2026 (AGM) and early September 2026 (H1 2026 results) decide whether the de-rating reverses or extends; everything else is noise. The setup is mixed, the calendar is unusually high-impact for a Swiss large-cap, and the next three months contain two binary events the bull and bear cases both need to survive.

What Changed in the Last 3-6 Months

The setup is dominated by four moves between January and early May 2026: a rally on 2025 fundraising, a brutal results-day reaction on 10 March, a disclosed CEO succession path, and a short-seller campaign. Earlier 12-month context (April 2025 tariff drawdown) still matters because realised vol and the death-cross both date back to that episode, but the 3-month window is what is pricing the stock today.

The narrative has rotated three times in five months. In January the question was "how fast can AUM compound to USD 450bn?" — record fundraising set up a bullish March print. From mid-March it pivoted to "is the predictable-compounder pillar broken?" — the FY25 deck contained the first explicit management-fee guide-down of the Layton era plus a soft walk-back on 2026 performance fees. By late April it shifted again to "are the marks real?" — the Grizzly report attacked the credibility component of the moat, and the firm's combative response (legal action, regulatory referral) raised rather than calmed the temperature. All three questions resolve, partially or fully, between 20 May and 1 September.

What the Market Is Watching Now

The live debate is unusual for a Swiss large-cap because three independent challenges to the franchise — distribution scale (vs Blackstone/Apollo), pricing power (the FY26 mgmt-fee guide-down), and accounting credibility (Grizzly) — are simultaneously priced into the multiple at decade extremes. The thing the market is not watching closely enough, in my read: the Q1 2026 trading update embedded in the April IR deck shows USD 8.3bn of gross client demand — annualising at the upper end of the USD 26-32bn FY guide — and direct realisations were up 54% YoY in 2025. The data supports the bull setup; the narrative is bearish. That gap is what a 3-6 month event path either crystallises or closes.

Ranked Catalyst Timeline

Five hard-dated events between today and early November 2026, plus three soft-window catalysts that could land at any point. Rank is by decision value to a PM, not chronology.

Impact Matrix

Of the ten ranked catalysts, five actually resolve the investment debate rather than just adding information. The other five are either price-irrelevant (ex-dividend), already-priced (Q1 trading update style updates), or beyond the six-month horizon.

Three of the six load-bearing catalysts resolve at or before 1 September 2026. The H1 print is the one event that touches all three live debates (pricing power, redemption stress, accounting credibility) in a single disclosure. Anything before 1 September is preparatory.

Next 90 Days

Inside today + 90 days (8 May to 6 August 2026), only two truly hard-dated events sit on the calendar — the AGM and the H1 AuM print — but each carries a payload of items that can move the stock independently of the calendar.

What Would Change the View

Three observable signals between now and early September would update the investment debate. First, the H1 2026 management-fee margin reading: a print at or above 1.20% confirms the 20-year band and ratifies the bull thesis on bespoke-mix durability; a print below 1.18% is a regime change that invalidates the moat thesis regardless of the rest of the print. Second, the H1 evergreen redemption disclosure: a moderation toward 8% annualised supports the BREIT-precedent risk premium starting to compress; a step toward 5% quarterly, or any peer-gating event before 1 September, re-prices the entire 37% evergreen book before PG can defend it. Third, the resolution path on the Grizzly allegations — through a clean PwC H1 review, AGM Q&A, or a subsequent-events note on named positions (Afileon, Forterro, Stada-Russia, Zenith Longitude). A clean read disposes of the forensic overhang; an emphasis-of-matter or regulator inquiry crystallises the bear case independent of operating numbers. All three sit inside the next four months.

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the franchise economics genuinely support a long at this valuation, but three load-bearing binaries (PwC FY25 audit opinion, H1 2026 evergreen redemption disclosure, the FY26 management-fee margin print) all crystallise inside 12 months and any one of them can break a core pillar.

The decisive tension is the management-fee margin: bull and bear are reading the same 1.24% number from opposite ends — the bull as a 20-year band that refused to break under fire, the bear as a one-way slide now 6bp from the floor with management itself guiding 2026 lower. Insider buying at 10:1 and a decade-cheap multiple put the weight of evidence on the bull side, but the bear has named specific, observable triggers — a dropped redemption KPI, a first PwC opinion on private fair values, a first-ever Layton-era management-fee guide-down — that aren't story risk, they're disclosure risk in the next two reporting cycles. The condition that would change the verdict to outright Lean Long is a clean PwC FY25 audit opinion with no emphasis-of-matter, paired with an H1 2026 print where the management-fee margin holds at or above 1.20%.

Bull Case

Bull's price target: CHF 1,430 by FY27 (≈18 months). Method: management's FY27 EPS guide of USD 78.77 (≈CHF 63 at consensus FX) × 22× P/E (10-year median multiple). Primary catalyst: H1 2026 results in September 2026 — three things must print: (a) management-fee margin holds at or above 1.20%, (b) performance fees inside the 25-40% guided band, (c) evergreen redemption rate moderates from the 11% annualised FY25 reading. Disconfirming signal: management-fee margin breaks below 1.18% in any reporting period — the first 20-year band-break invalidates the moat thesis regardless of the rest of the print.

Bear Case

Bear's downside target: CHF 600 (≈30% below the 8 May 2026 close of CHF 879) on a 12-month horizon. Method: FY26 EPS reset to CHF 42 (vs consensus near CHF 51) on the management-fee guide-down, perf-fee compression to the low end, and AuM deceleration; 14× P/E (below the 16.5× 10-year low) for FRE-quality + NAV-mark contingent liability + distribution-scale disadvantage; CHF 42 × 14 = ~CHF 588, rounded to CHF 600. Primary trigger: H1 2026 trading update showing evergreen redemption rate stepping toward the 5% quarterly gate threshold, OR a PwC FY25 audit emphasis-of-matter on private investment fair values. Cover signal: a clean PwC FY25 opinion combined with H1 2026 evergreen disclosure showing net inflows resuming and 2026 perf fees tracking above 30% of revenue.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. The weight of fundamental evidence sits on the bull side: 62.8% EBITDA margin and 54.8% ROE are the cleanest economic-moat fingerprint in the listed alternative-asset peer set, the multiple is at a 10-year low, and a 10:1 informed-insider buy-to-sell ratio at the CHF 780-900 zone is the single strongest tape signal in the file. The decisive tension is the management-fee margin at 1.24% — both sides agree on the number; the bull reads it as the 20th year inside the band, the bear as 6bp from the floor with management itself guiding 2026 lower for the first time in the Layton era. Three named binaries — the PwC FY25 audit opinion, the H1 2026 evergreen redemption disclosure, and the FY26 management-fee margin print — all land inside 12 months, and the dropped redemption KPI in the FY25 deck is a forensic red flag, not narrative. The condition that flips this to outright Lean Long is a clean PwC FY25 opinion with no emphasis-of-matter on private fair values, paired with an H1 2026 management-fee margin reading at or above 1.20% and net evergreen inflows resuming. Until those land, the cheap multiple is partial compensation for binary risk you can date.

Moat — What Protects This Business, If Anything

A moat is a durable, company-specific economic advantage that lets a business defend its returns, margins or share against well-funded rivals over a full cycle. "Narrow", "no", and "not proven" are valid conclusions.

1. Moat in One Page

Conclusion: Narrow moat. Partners Group has a real, evidenced advantage inside one clearly bounded niche — bespoke institutional separate accounts plus pioneer-launched evergreen private-markets products, together 67% of CHF/USD-equivalent AuM — but it is not a wide moat in the textbook sense. The franchise earns a 62.8% EBITDA margin and a 54.8% ROE that no listed pure-play peer matches, on a management-fee rate that has stayed inside a 1.18–1.33% band for 20 straight years. That durability is real and shows up in the numbers. But the source of advantage is intangible (bespoke architecture, evergreen first-mover credibility, multi-asset cross-sell), not structural (insurance flywheel, owned distribution rails, regulated monopoly), and it sits next to two competitors — Blackstone in distribution scale, Apollo in permanent insurance capital — whose advantages PGHN has explicitly chosen not to replicate. The narrow rating is therefore an honest one: PGHN beats every peer on margin and ROE inside its niche, but loses on absolute scale, distribution velocity, and credit-franchise depth, and the moat narrative depends critically on the evergreen book not breaking.

Strongest evidence the moat works: (1) the 20-year management-fee-margin band that has refused to compress through three cycles of fee compression in public-market asset management, (2) a 62.8% EBITDA margin that beats Blackstone (50.5%) by 12 percentage points on one-seventh the AuM, and (3) bespoke + evergreen at 67% of AuM versus mid-20s for the peer median.

Biggest weaknesses: (1) the management-fee rate has drifted from 1.36% (2017) to 1.24% (2025), already a 12-bp erosion, with the bespoke mix doing the protecting; (2) PGHN has no insurance balance sheet and no owned wealth-distribution platform, both of which competitors are actively widening as moats of their own; (3) the April 2026 Grizzly short report on Master Fund private-asset valuations creates contingent risk to the perceived integrity of the fee-and-carry engine.

Moat rating: Narrow. Weakest link: distribution-scale gap versus Blackstone in private wealth.

2. Sources of Advantage

Five candidate sources of advantage exist for a private-markets manager. PGHN has evidence for three of them, partial evidence for one, and no real claim on the fifth. The table below makes each claim, names the economic mechanism in plain English, and rates the proof quality.

The high-confidence moat element is switching cost in bespoke mandates. The medium-confidence elements (evergreen first-mover, multi-asset workflow) are real but copyable; the cost/scale element is a consequence of the mix advantage, not an independent moat. Network effects do not exist in any rigorous sense for this business and should not be in the bull-case stack.

3. Evidence the Moat Works

Six pieces of evidence — three supportive, two mixed, one refuting — drawn from filings, peer comparisons and recent disclosures. The point of this ledger is to test the alleged moat against the numbers, not to advertise it.

The band chart is the single most useful moat signal in the file. A franchise without pricing power would have shown a steady downward staircase as fee compression in public markets bled across into private-markets fund fees. PGHN's band has refused to compress meaningfully — a real moat signature. But the slow drift toward the lower edge of the band (1.24% is the second-lowest reading in 20 years) is also exactly what you would expect if the moat were narrowing rather than widening.

4. Where the Moat Is Weak or Unproven

Four explicit weaknesses, written so the bull case cannot dismiss them.

1. The bespoke premium is a one-shot mix shift, not a compounding pricing-power story. PGHN moved from a fund-of-funds model to a bespoke-and-direct model over 2010-2020. The fee margin held inside the band because every percentage point of mix shift to bespoke offset a percentage point of fee compression in legacy fund products. That is impressive but it is not the same as raising the price on an existing customer set. Once mix shift is largely complete (67% bespoke + evergreen is already high by industry standards), the moat is the defence of that position rather than its expansion. Below 1.18% on the fee margin is the regime change line.

2. Evergreen redemption optionality is a moat tail-risk, not a moat strength. Evergreens accounted for 37% of AuM at end-FY2025 and were explicitly the channel that drove 2024-25 inflows. They are also the channel where redemption gates kick in at 5% per quarter under industry norms, where Steffen Meister told the FT in April 2026 that PGHN "will gate" if redemptions exceed thresholds, and where 2025 saw 11% annualised platform-level redemptions concentrated in mature PE. A real moat product does not have a 5% quarterly gate as its primary defence mechanism. The closed-end book is bond-like by design; the evergreen book is not.

3. Distribution scale gap is structural and widening. Blackstone raised USD 43bn from private wealth in 2025 (+53% YoY); PGHN's full-year 2026 gross client demand guidance across all channels is USD 26-32bn, and Ares' Q1 2026 fundraising alone (USD 30bn) was effectively equal to PGHN's full-year ambition. PGHN's response is the right one — JVs with Deutsche Bank (evergreen launch), PGIM (multi-asset), Generali (credit secondaries) — but those are partnerships, not owned distribution. A moat in distribution requires the rails to be yours, not rented.

4. No insurance flywheel, by management choice. APO (Athene), KKR (Global Atlantic) and BX (insurance partnerships) recycle permanent insurance capital into private-credit origination, which gives them a structural fee-plus-spread advantage PGHN cannot match. Management has been explicit that PGHN will not buy a carrier and instead positions its CHF 1.7bn co-investment book as the alignment mechanism. That is a defensible choice — it preserves the asset-light model and avoids the regulatory complexity of an insurance balance sheet — but it forecloses the single biggest moat-builder in the alternatives industry over the next decade.

5. Moat vs Competitors

This is not a peer-valuation exercise (covered separately) — it is a comparison of what each peer's moat is built from, where they are stronger than PGHN, and where PGHN is stronger than them. Peer disclosures on bespoke share and evergreen share vary; figures below are directional from staged 10-Ks and CMDs.

PGHN tops the field on bespoke mix, margin and ROE; sits in the middle on platform breadth; loses on distribution rails (vs BX) and on insurance flywheel (vs APO and KKR). A "wide moat" company would dominate at least one dimension and at least match peers on the others. PGHN dominates margin/ROE by mix but is structurally exposed where peers are strongest — the asymmetry that supports a narrow moat conclusion.

6. Durability Under Stress

A moat exists only if it survives stress. The table tests PGHN's claimed advantages against six stress scenarios drawn from the actual recent record (2022 rate shock, 2025 evergreen redemptions, the Grizzly short report) and from forward catalysts already in motion.

The single stress test the moat has passed is the 2022-2024 exit drought: management fees kept compounding, EBITDA margin barely moved, the variable-comp absorber worked as designed. The single stress test the moat has not yet been put through is a real evergreen gate event. BREIT's 2022-2024 episode is the precedent — BX absorbed the reputational damage but the recovery took 18+ months. PGHN's 11% annualised 2025 redemption rate is uncomfortable but not yet at the gate trigger; this is the most consequential single watchpoint.

7. Where Partners Group Holding AG Fits

The moat does not live evenly across the firm. It lives in two places — bespoke separate-account mandates (33% of AuM, mostly large institutional LPs) and the multi-asset thematic platform that supports those mandates — and is at risk in two others: the evergreen book (37% of AuM) and the legacy commoditised closed-end funds that are slowly tail-down (the residual ~30%).

PGHN is a narrow-moat firm in its bespoke segment, an exposed first-mover in its evergreen segment, and a commodity manager in its legacy closed-end book. The headline moat narrative captures only the first of those three. Underwriting PGHN as a single homogeneous franchise mis-prices both the durable parts and the fragile parts; the right model values FRE durability differently for each bucket.

8. What to Watch

Five quarterly signals that move the moat verdict in one direction or the other. Track these instead of headline EPS noise.

The first moat signal to watch is the management-fee margin (% of avg AuM) — a single number, disclosed annually, that has stayed inside a 1.18-1.33% band for 20 years and that would be the first to break if competition is winning. A 5-bp drift is normal annual mix noise; a 15-bp break below the band would be the first signal that PGHN's moat is closing rather than widening.

The Forensic Verdict

Partners Group's reported earnings broadly track economic reality, but the forensic risk has stepped up materially in the last 12 months. Three things drive that: an active short campaign by Grizzly Research on 30 April 2026 alleging that close to 40% of the Master Fund's Western European holdings are mismarked, an auditor change at the May 2025 AGM (KPMG to PwC after a 2022-initiated tender), and a 41% jump in receivables in FY2024 against single-digit revenue growth that resolved only as performance fees printed in FY2025. None of these is a confirmed misstatement, but together they make the private valuation discipline that supports CHF 819M of FY2025 performance fees the load-bearing forensic question. Three years of CFO/NI of 0.91 and FCF/NI of 0.85 indicate adequate cash conversion, and the conservative "lower-of" performance-fee recognition framework (50% NAV stress, claw-back, 40% employee profit-share) is the cleanest offsetting evidence. The single data point that would most change the grade: a clean PwC FY2025 audit opinion with no emphasis-of-matter on private investment fair values.

Shenanigans scorecard — all 13 categories

Breeding Ground

The breeding ground is moderate, not friendly: incentive design and audit oversight are reasonable, but private-asset dependence and an active short campaign raise the latent risk of an accounting flashpoint.

The auditor handover is the cleanest single governance event to flag. Lead auditor Philipp Rickert was due for the seven-year rotation regardless, the tender was opened in 2022, and PwC's audit fees came in identical to KPMG's. That is the textbook benign rotation. What raises the bar is timing — PwC inherits an audit cycle in which Master Fund private-asset valuations will draw forensic attention from external parties for the first time in over a decade. The Risk & Audit Committee held five meetings in 2025 with both KPMG and PwC participating in two of them; a clean PwC opinion on FY2025 (filed 10 March 2026 on the FY2024 cycle) and a clean opinion on FY2025 audited under PwC will be load-bearing.

Earnings Quality

Reported earnings reconcile reasonably to fundamentals, but the FY2024 receivables build, the FY2025 performance-fee surge, and the dependence on private-asset fair-value marks together create three judgment areas that deserve direct testing.

The FY2024 anomaly is real: receivables grew 41% on revenue of +9.8%. By 31 December 2024, CHF 1,155M of receivables sat against CHF 2,136M of revenue — a DSO of 197 days. The FY2025 print resolved it: receivables nudged down to CHF 1,135M while revenue rose 20% to CHF 2,563M, dragging DSO back to 162 days. Two mechanics explain it. First, performance fees recognized late in FY2024 (perf fees up 39% YoY) often invoice and collect months after recognition. Second, short-term treasury loans to client funds (CHF 1,634M at end-FY2024 vs CHF 1,657M at end-FY2025) flow through receivables-adjacent buckets. Neither mechanic looks like aggressive top-line acceleration, but both make receivables a less-clean tracking variable than for traditional fee-only managers.

Performance-fee dependence has stepped from 19% to 32% of revenues in two years. Management's published model is conservative — performance fees on closed-ended programs are recognized as the lower of (1) realized-investment fees and (2) realized-plus-stress-tested-NAV fees, with stress at 50% of NAV (up to 100% in select cases). On open-ended evergreens, fees use the high-water-mark mechanism on quarterly NAV development. That framework is cleaner than peers that book carry on a "1A" full mark-to-NAV approach. The risk is not the framework but the input — the NAV applied to step 2 — which is exactly where the Grizzly allegation lives.

EBITDA margin has held in a 1.7-point band for five years. Management explains it via fixed cost-income targets (40% on new management fees) and the mechanical 40% performance-fee comp share. That is a credible operating story. The forensic question is whether the band masks underlying lumpiness — and the answer is partially yes: the floor is held by performance-fee revenue plus the matched performance-fee comp accrual, both of which key off the same NAV inputs.

Cash Flow Quality

Year-by-year operating cash flow is volatile, but a multi-year average shows reasonable conversion. The biggest sensitivity is working capital — specifically the swing in receivables and the gross flows in client treasury loans — and the share of FY2025 CFO recovery that is genuinely durable versus a reversal of FY2023-FY2024 working-capital pressure.

The single-year CFO/NI ranges from 0.37 (FY2018) to 1.43 (FY2020). Annual cash-flow grades on this stock alone are misleading; the multi-year frame is the only honest one. Three-year FY2023-FY2025 totals: CHF 3,392M of net income, CHF 3,092M of CFO, CHF 2,867M of FCF — ratios of 0.91 and 0.85 respectively. After acquisitions of CHF 109M, three-year FCF after acquisitions runs CHF 2,758M, just over 81% of net income. That is acceptable for a private-markets manager but it is not the textbook 1.0+ that pure management-fee asset managers print.

The CHF -550M working-capital drag in FY2018 and CHF -857M drag in FY2021 are the two clearest signals that operating-cash-flow timing on this business cannot be assumed to follow earnings. The recovery in FY2025 (+CHF 122M) reverses two prior years of build-up; absent that swing, FY2025 CFO would have been roughly CHF 1,393M, putting CFO/NI closer to 1.10 — still healthy, but two-thirds of the headline 1.20 is normalisation not new operating power. That reading frames the Empira-acquired CFO uplift more conservatively too.

The CHF 2.0B reversal in net debt from FY2021 to FY2025 is the consequence of CHF 4.6B of dividends and CHF 1.5B of buybacks against CHF 2.7B of FCF over the same five years. The shortfall has been funded with CHF 1.5B of corporate bonds and rising credit-facility utilisation (CHF 1,056M drawn at end-FY2025 against a CHF 2,791M facility). Management's APM "Total net debt" of CHF 400M nets short-term loans to clients (CHF 1,657M) against gross debt — that netting is mechanically correct under their treasury-management model but worth flagging because it creates a CHF ~1.7B gap between APM net debt and a literal IFRS read.

Metric Hygiene

Disclosure quality is high by Swiss-listed asset-manager standards, but management-introduced metrics consistently frame the business toward stability. Three definition shifts in 24 months are worth tracking.

The single metric definition that matters most is the dropped redemption disclosure. Per Financial Times reporting (April 2026), withdrawal requests at the flagship US evergreen private equity fund hit USD 750M in Q3 2025 — double the same quarter a year earlier — and the fund entered net redemptions for the first time in 2024. Partners Group has publicly said it would impose limits on investor withdrawals if redemptions rise sharply. Pulling redemption inflow/outflow netting out of guidance just as the headline line is deteriorating is the textbook disclosure pattern that a forensic reader is trained to flag.

What to Underwrite Next

Five concrete diligence items, in order of materiality:

The accounting risk on PGHN sits between a footnote and a position-sizing limiter. Three-year cash conversion is acceptable, the performance-fee recognition framework is conservative, the auditor change is procedurally normal, and the breeding ground is constrained by multi-jurisdiction regulation. What is not yet known — and only the next two reporting cycles can answer — is whether the externally challenged private-asset marks survive closer scrutiny, whether evergreen redemption pressure forces gating that dents fee revenue, and whether the FY2025 working-capital tailwind reverses. Until those three clear, the appropriate underwriting stance is a 10-15% valuation reserve relative to a clean private-markets manager comp, the 95% dividend payout treated as informationally tight rather than safe, and FY2025 CFO/NI of 1.20 not assumed as a new run rate.

The People

Governance grade: A−. Three founders still own 15% of the company, sit on the board for 2–3 days a week, and have not diluted shareholders by a single share since the 2006 IPO; an independent former FINMA chief and a former AXA P&C CEO chair the audit and risk committees. The grade is held back from "A" by founder voting power that no shareholder can challenge, and by a long-term incentive structure (MCP/ExMCP) whose payouts depend on private-fund returns that outsiders cannot verify until carry crystallises 8–14 years out.

The People Running This Company

Partners Group is run by an unusual two-tier structure: an eight-person board that includes the executive chairman and the three founders (who do not have line-management roles but each commit 2–3 days per week), and a separate ten-person Executive Team led by US-based CEO David Layton. Eight people matter for the trust judgment.

David Layton (CEO since 2018, age 50). Joined Partners Group in 2005, ran private equity Americas, became co-CEO with André Frei in 2018, sole CEO from 2021. Layton is the architect of the firm's US push and its move from fund-of-funds origins into direct private equity at scale (now $83bn AUM). He lives in Denver, draws his cash compensation in USD, and owns 20,220 vested shares plus 5,203 unvested and 48,120 options — small relative to the founders, but his vested shareholding nearly doubled in 2025 (10,153 → 20,220), evidence of share-purchase behaviour rather than just option exercise.

Steffen Meister (Executive Chairman since 2014, age 55). Mathematician (ETH Zurich), joined PG in 2000, served as CEO 2005–2013, transitioned to chair in 2014. Owns 359,189 shares (≈1.35%) — not founder-scale but ~CHF 280m at year-end 2025 prices. Allocates 3–5 days per week. Chairs the Investment Oversight Committee, so he remains operationally embedded, not a ceremonial chair.

The three founders — Alfred Gantner, Marcel Erni, Urs Wietlisbach (all 1996 vintage). Each owns ≈5% directly, together 15.1%, all are Goldman Sachs alumni, none holds a line-management role. Erni was CIO until 2017; Gantner was CEO 1996–2005, then Chairman 2005–2014; Wietlisbach has always run client-facing strategy. They sit on the Investment Oversight Committee (Erni, Gantner) and Client Oversight Committee (Wietlisbach as chair). They are 57–65 years old and still highly active, but the question of how the board looks once they begin to step down is the single biggest unresolved governance question.

Independent directors worth knowing. Gaëlle Olivier (Lead Independent Director, RAC and OOC chair) — former AXA P&C CEO, Société Générale Asia-Pacific CEO and Group Deputy GM; serious buy-side, derivatives, and operational credentials. Dr. Urban Angehrn (joined May 2025) — former CEO of FINMA (Switzerland's financial regulator, 2021–2023) and former Group CIO of Zurich Insurance; combines regulatory and asset-allocation experience that PG specifically needs as it grows insurance partnerships. Flora Zhao (NCC chair) — 30 years at BP (President Gas Asia) and AES; brings energy infrastructure and Asia-Pacific lens to investment oversight. Anne Lester — 30 years at JP Morgan AM, ex-Head of Retirement Solutions; relevant for PG's evergreen / wealth distribution push.

What They Get Paid

CEO David Layton was awarded CHF 15.93m for 2025, of which CHF 10.0m actually vested or paid in cash and shares — the gap between the two numbers is the headline tension in this comp plan, and the report itself flags it (the Compensation Report disclosed multi-year realized pay for the first time in 2024). Total Executive Team compensation was CHF 67.4m across 10 people, down 3.3% from CHF 69.7m in 2024 because the equity LTI pool was cut −4% on the back of a Management Fee EBITDA growth miss.

Is pay sensible? Three answers, depending on what you compare against.

Against peers: PG explicitly states its CEO and ExTe total comp falls below the median of US mid-market private-markets managers it benchmarks to (Blackstone, KKR, Apollo, Ares, Carlyle, Brookfield). For a firm with CHF 26.2bn market cap and ~CHF 1.5bn EBITDA, CHF 16m for the CEO is mid-range and below US peers.

Against performance: The 2025 LTI pool fell −4% because the Management Fee EBITDA growth came in at +3% versus a 10% target (a 0.33x quantitative factor on financial performance). The qualitative factor of 1.23x partially offset this. The system functioned as designed — a miss produced a cut, not a flat-line. Pay-for-performance is real but blunt: a 70% miss on the headline financial target produced a 4% pay cut, because the qualitative override is large (50% of the equity LTI pool).

Against what was actually delivered: The realized pay table is more honest. Layton received CHF 10.0m in 2025, dominated by a CHF 5.7m MPP vintage payout (carry from MPP 2018 finally hitting). His MCP carry payout was just CHF 571k; the bulk of his CHF 8.3m MCP grant for 2025 will not hit for 8–14 years and is highly contingent on private-equity exit performance.

Are They Aligned?

This is where Partners Group is uncommonly strong. Founder ownership is large, direct, and unencumbered; insider buying outweighs selling by an order of magnitude over the past 90 days; the firm has not issued a single new share since 2006; and minimum-shareholding rules force at-risk equity onto the executive team.

Ownership and control

The three founders together hold 15.14% directly. With Steffen Meister's 1.35% and other Executive Team holdings, internal ownership is approximately 16.5% — a level that gives the founder bloc a blocking minority on any special resolution requiring a two-thirds quorum (notably amendments to transfer restrictions). They cannot dictate to other shareholders, but no hostile shareholder action can succeed without them. That is a genuine governance feature: a hostile bid would require founder consent.

The founders operate under a formal shareholders' agreement filed with SIX Exchange Regulation, with Gantner acting as their representative.

Insider buying versus selling

Insider activity over the last 90 days shows ≈CHF 29.7m of executive-director purchases against ≈CHF 2.9m of sales — a 10× buy:sell ratio. The buys clustered in March–April 2026 at price levels of CHF 780–900, after the share price had fallen ~13% over the same window. This is unusually loud insider conviction. By contrast, in November 2025 there was a clean cluster of sales totalling ~CHF 7m at CHF 1,090–1,148 — the founders/executives were net sellers near the highs and net buyers on weakness, which is the pattern shareholders should want to see.

Dilution and option grants

PG has not issued a single share from conditional capital since the 2006 IPO. Total share count remains 26.7m. All MPP/SPP/MCP payouts have been delivered from treasury (currently 916,865 shares, 3.43% of capital, bought back from market). A capital band approved in 2024 allows up to 2.67m new shares (10% dilution) until May 2029, but it is unused. Conditional capital of 4.005m shares for option grants exists but has remained untapped for 19 years.

Related-party behaviour

The most material related-party item is "waived fees" — the value of fees Partners Group does not charge on board/executive co-investments alongside clients. For 2025 these totalled CHF 15.3m for the eight-person board, dominated by Alfred Gantner (CHF 6.06m), Urs Wietlisbach (CHF 5.71m), and Marcel Erni (CHF 3.46m). This is not pay — it is the dollar value of fee discounts on personal capital these individuals have committed alongside clients (typically 1% of programme size). It indicates the founders are deploying their own capital into PG funds at scale, which is a strong alignment signal in itself, but the fee waivers are large enough that they merit transparency. PG discloses them line-by-line, which is the right standard.

There are no loans outstanding to any director or executive (audited). There are no severance agreements, no golden parachutes, no change-in-control acceleration. Bonus-malus / clawback provisions exist but have never been triggered.

Capital allocation behaviour

PG has paid an uninterrupted, growing dividend for two decades, and its dividend policy commits to a payout ratio target. It has not done a buyback that destroys shareholder count (the 3.43% in treasury is held to deliver LTI awards without dilution). Capital expenditure is essentially zero (it's an asset manager). This is a textbook capital-light, cash-return business; the founder-aligned board has not deviated from that model in 20 years.

Skin-in-the-game scorecard

Score: 8.5 / 10. Founder ownership is real (~15% direct) and locked under a shareholders' agreement; the executive chairman and CEO own meaningful stakes (CHF 280m and CHF 25m+ respectively at year-end 2025); minimum-shareholding rules force 6× salary for the CEO and 3× for ExTe; insider buying dominates selling 10:1 over recent quarters; no dilution since IPO; no severance shenanigans. Half a point lost because two of ten ExTe members (CFO Joris Gröflin and COO Michael Marquardt, both relatively new) are not yet compliant with their minimum-shareholding hurdles. A full point lost because the MCP/ExMCP plans pay out on private-fund returns whose modelling is opaque to outside investors — alignment exists, but verifiability does not.

Board Quality

Partners Group's board is small (eight), 50% independent, and weighted toward people with operating experience in financial services, asset management, and regulation. The expertise mix is unusually deep for a Swiss mid-cap.

What the board does well. The three committees that police management — RAC, NCC, Operations Oversight — are all chaired by independent directors. The Lead Independent Director (Olivier) chairs the two most important of those (RAC and Operations Oversight) and also sits on NCC. RAC met five times in 2025, with the external auditors attending all five, and meetings averaged 3–3.5 hours. The independent directors collectively dedicate 1–2 days per week. None of them sits on a Partners Group portfolio-company board in a way that compromises independence, though several hold seats on PG's local subsidiary boards (e.g., Lester on the US entity, Olivier on the UK entity, Zhao on Singapore) — this is a feature not a bug for a regulated cross-border firm.

Where it is genuinely independent. The independence test PG itself describes is "limited financial dependence" plus no line-management role. By that standard, the four are clean — none has ever held a senior executive role at PG, none has any business relationship beyond co-investing in PG products on the standard employee-program terms.

Where to push back. The Investment Oversight Committee is chaired by the executive chairman (Meister), with founders Erni and Gantner as members and CIO as non-voting member. Investment risk decisions effectively flow through executive-aligned directors. The board's defence is that the IOC's role is value-creation oversight rather than risk veto — and the RAC, chaired by an independent director, is the formal risk committee. That is defensible, but a sceptical investor should note that the people choosing investments and the people overseeing them have substantial overlap.

Compliance and conduct. Bonus-malus / clawback has never been triggered. No FINMA, SEC, FCA, or MAS enforcement action was disclosed in the 2025 governance report. The 2025 AGM passed the 2024 Compensation Report with 87% approval — a clear pass but down from the 90%+ levels of earlier years and a signal that ISS / Glass Lewis are watching the ExMCP cap and the size of CEO pay.

The Verdict

Letter grade: A−.

Strongest positives. Founder ownership of ~15%, directly held under a shareholders' agreement, with each founder owning more in shares than they have ever earned in salary; zero share dilution since IPO 19 years ago; net insider buying of ~CHF 30m versus ~CHF 3m of sales over the last 90 days, including buying on a 13% pullback; independent directors of unusual calibre (former AXA P&C CEO, former FINMA chief, former JP Morgan AM head of retirement, former BP Asia Gas president); compensation cap of 1.2× on the new performance-carry plan and an 8–10× LTI cap to total base; the LTI pool actually fell −4% in a year of weaker EBITDA growth; bonus-malus / clawback exists; no severance, no parachutes, no loans; 87% AGM approval of the comp report.

Real concerns. Founders + executive chairman together hold a blocking minority on any two-thirds vote — there is no path to forcing a strategic change without their consent, which is a feature for long-term holders but a fact for activists. Two of ten ExTe members are not yet compliant with minimum-shareholding rules; the executive chairman's 1.35% is much smaller than the founder stakes, which leaves succession concentrated. The Investment Oversight Committee is dominated by executive-aligned directors. The new ExMCP plan ties a meaningful chunk of CEO pay (CHF 8.3m of CHF 15.9m in 2025) to private-fund returns that crystallise 8–14 years out, which means the headline pay number overstates near-term economic burden but creates long alignment without real-time accountability.

The one thing that would change the grade. Upgrade trigger: a clear, public succession plan for the three founders — naming next-generation partners with explicit timelines for board roles — would move this to A. Downgrade trigger: any meaningful selling by founders Wietlisbach, Erni, or Gantner that takes any of them below 4% would shift the grade to B+; a covenant breach or AGM rejection of the comp report (under 70%) would push it to B.

How the Story Has Changed

Through 2023 and 2024, Partners Group's story was about gracefully riding out a private-markets winter — exits delayed, performance fees soft, but management held the line and pushed bespoke solutions, evergreens and a fifth asset class (royalties) as the next leg of growth. 2025 looked like vindication: record CHF 26 billion raised, performance fees +60%, AuM at USD 185 billion, a first-ever Capital Markets Day, a USD 450 billion 2033 ambition. Then the stock told a different story — down roughly 42% from its 2021 peak of CHF 1,513 to CHF 879 by May 2026, with a brutal April-2025 tariff shock and a quiet downshift in 2026 management-fee growth. Management has mostly hit its quantitative guidance, but the 2026 framing — "lower part" of the 25–40% performance-fee range, lower management fees year-on-year — is the first soft walk-back in the David Layton era, and the market is treating the long-dated USD 450 billion target as a "show me" story.

1. The Narrative Arc

The chart below traces the share price against the moments management itself flagged as inflection points in its annual letters and capital-markets-day decks.

The shape that matters: a 20-year compounder that did not crack in 2008, broke meaningfully in 2022, recovered, then stalled. Three of the four worst peak-to-trough moves in the firm's listed history have happened in the last 48 months — 2022 rate-shock, the April-2025 tariff drawdown, and the slow drift through 2025–H1 2026. The story before 2022 was "private markets are taking share from public markets, full stop." The story since 2022 is more conditional: "we are taking share within a stagnant industry, and our platform converts faster than peers."

2. What Management Emphasized — and Then Stopped Emphasizing

Topic intensity across the four most recent reporting cycles. Cells are scaled 0–5 by mention density and prominence (header slides, CEO letter, prepared Q&A).

A few patterns worth pulling out:

• The "private markets keep beating public markets" line is gone. It was the opener in March 2024. By March 2026, the headline is the inverse — "we gained market share in the new normal," with industry fundraising "in continued decline." The reference frame shifted from absolute growth to relative share.
• Royalties peaked as a talking point in FY2024 and has cooled. Sold as the "fifth asset class" with 30 investments in 2024, framed as a "first dedicated, scalable multi-sector royalty offering." By FY2025 it has USD 1 billion AuM, less than 1% of the firm, with no realizations and "hold-for-life" performance not disclosed. Still strategic; no longer a banner.
• Distribution JVs replaced royalties as the headline platform story. BlackRock, Deutsche Bank, PGIM and Generali — none mentioned in FY2023 — now sit at the top of the FY2025 letter. Combined contribution so far: ~USD 1 billion of fundraising. Promise is much larger than realized AuM.
• The USD 450 billion / 2033 target appeared first at the March 2026 Capital Markets Day (the firm's first since IPO in 2006). That's a 13% AuM CAGR over eight years from a base where 14% AuM growth in 2025 (ex-FX, redemptions, performance) was framed as ahead of trajectory. The bar was set just above the most recent print.
• Software underweight is a new defensive shield. "Software exposure in direct lead equity and private credit both less than 2% of AuM" — absent from FY2023, prominent in FY2025. Specifically positioned to deflect AI-disruption concerns about the leveraged-loan book.

3. Risk Evolution

The risks management talked about did not stay the same.

What changed:

• Newly visible. US tariffs (April 2025 wiped out CHF 15 billion in market cap in days). Private-credit evergreen run risk (the FY2025 deck dedicated a slide to "de minimis exposure to private-wealth credit evergreen, ~USD 500m, 0.3% of AuM" — a defensive disclosure that did not exist before; the topic appears to be reactively addressing a peer concern). AI disruption — flipped from opportunity (Steffen Meister's 2024 "intelligence as a service" framing) to defensive ("we limited software exposure to less than half the industry average").
• Less prominent. The exit-market complaint that dominated 2023 calls and the 2024 mid-year miss disappeared by H1 2025 once realizations were up 47% YoY. Rate-cap real-estate write-downs, a 2023 headline, faded; FY2025 calls real estate "still undergoing disruptive change" without quantifying.
• Persistent. CHF strength against USD/EUR has been a 2–4% revenue drag in every period since FY2023 and is still flagged at -0.5% on FY2025 EBITDA margin. Management has not hedged this away — they explain it; clients absorb it.

4. How They Handled Bad News

Two clear stress tests in the look-back window: the H1-2024 performance-fee miss, and the April-2025 tariff drawdown. Both followed the same playbook — acknowledge, blame timing, restate the long-term thesis, do not cut multi-year guidance.

Episode	Pre-event tone	Post-event message
H1 2024 (Sep 2024 release) — performance fees -39% YoY to CHF 161m, profit -8%	March 2024: "strong year for new mandate conversions"; expected exit-market recovery in H1 2024	September 2024: market recovery "has not yet translated into activity in the transaction markets"; "delayed several planned exits" — but full-year guidance held. Outcome: H2 2024 realizations +53%, FY perf fees +38% — they were right
April 2025 tariff drawdown — stock -25% in two weeks; CHF 15bn market-cap loss	March 2025 Q4 release: 2025 fundraising USD 26-31bn, perf fees 20-30% of revenues	September 2025 H1 release: fundraising guidance cut to USD 22-27bn at the bottom; perf fees raised to 25-40%. JPMorgan cut its capital-commitment forecast from USD 24.5bn to USD 22.5bn. Outcome: full-year fundraising landed at USD 26bn — exactly the new low end
March 2026 FY2025 print — EPS missed consensus by ~3%; stock had already drifted from CHF 1,090 to CHF 819 ahead of results	January 2025 communication: 2025 perf-fee range raised to 25-40% on the back of "exit pull-forward"	March 2026: "lower part of 25-40% guidance expected for 2026 due to 2025 pull-forward"; explicit warning of "lower management fees in 2026 vs 2025." A quiet walk-back, not a cut

"We experienced significant progress in our exit pipeline in the second half of 2024, driven by the sale of direct assets. This lifted full-year realizations to USD 18 billion (+53% YoY)."

— David Layton, March 2025

Used here because the wording is the entire post-miss playbook in one sentence: H2 fixed H1, reset the year, no apology.

5. Guidance Track Record

Where the score gets earned.

The pattern: management has met or beaten every quantifiable annual promise that has been completed. The two open items — the 2026 fundraising range and the 2033 USD 450 billion ambition — are also where the soft walk-back risk lives. The 2026 management-fee call is the first explicit guide-down in the window.

Credibility: 7/10. Promises are quantitative, narrow, and almost always hit. Deductions: (1) the 2026 management-fee guide-down is the first time the "compounder" framing has wobbled inside the Layton era; (2) the USD 450 billion 2033 ambition was unveiled at a CMD held only because the firm needed to refresh the long-term story after a 42%-from-peak drawdown — the timing reads defensive; (3) royalties were sold as a scalable platform and remain sub-1% of AuM after two years. Nothing flags as misleading or unmet — but the framing has gotten more elastic.

6. What the Story Is Now

Current pitch (FY2025 Annual Report, March 2026): Partners Group is the "all-weather" private-markets platform that takes share when the industry stalls; bespoke solutions are 67% of AuM; five asset classes including royalties; record fundraising; distribution joint ventures with BlackRock, Deutsche Bank, PGIM and Generali; USD 450 billion 2033 target at a 13% CAGR.

What has been de-risked since 2023. Exit pipeline conversion (proven through 2024 H2 and 2025); performance-fee step-up to 30%-plus of revenues (delivered); platform breadth (Empira, royalties, JVs all completed or live); EBITDA margin stability (~63% through FX and acquisition headwinds).

What still looks stretched. The USD 450 billion target requires no further compression in fee margins, no extended tariff/geopolitics drag, and a genuine ramp of the JV channels — none of which is yet visible in 2025 numbers. Royalties remain a logo without scale. The 2026 management-fee guide-down — even mild — breaks the "predictable-compounder" pillar of the bull case. The stock has paid for the doubt: -42% from peak, dividend yield now 5%, the highest since 2008.

What the reader should believe. The execution machine works. Management says, then does, with a small lag. The CFO function is conservative. The platform is genuinely differentiated on the bespoke-solutions axis.

What the reader should discount. That every long-dated number management volunteers will print on the high end. The 2033 ambition is a North Star, not an actuarial estimate. JVs and royalties are options, not assets. The narrative tilt toward "we outgrew the industry in a hard year" implicitly concedes the industry is hard — and that the public market is right to apply a different multiple to private-markets compounders than it did in 2021.

The story is simpler than it was in 2024 (more focused, more "platform-and-distribution"), but the risks are now more visible and more concentrated than at any point in the last decade. That gap is what the market is currently pricing.

Financials — What the Numbers Say

Partners Group is a USD 185bn AUM Swiss alternative-asset manager whose financial statements look almost nothing like a "normal" company's. Two ideas dominate the page that follows. First, this is a fee-and-carry compounder with extreme operating margins — a 63% EBITDA margin on CHF 2.56bn of FY2025 revenue is closer to a software franchise than to a bank or broker. Second, the cash-flow profile is jagged because performance fees and carried-interest receivables move in cycles tied to private-market exit activity, which means earnings power has to be read as a five-year average, not a single print. FY2025 looks like the start of a new realization cycle: revenue +20% YoY, operating profit +18%, free cash flow up 84% YoY to CHF 1.51bn (mostly via reduced capex), leverage still trivial at 0.3× net debt / EBITDA, and the stock now trading at 20× earnings — well below its decade median (24×) and at a meaningful discount to listed US alternatives peers (BX 40×, KKR 50×, EQT 54×). The single financial number that matters next is whether performance income lands inside the new "25–40% of revenues" guidance corridor in 2026 and 2027 — because a slip back to the 2018-2020 trough range is what would invalidate the current re-rating thesis.

How to read this page. Free cash flow is the cash left after the firm pays its operating costs and capital expenditures — the discretionary cash available to pay dividends, buy back stock, or repay debt. EBITDA margin is operating profit before depreciation and amortization, divided by revenue — the cleanest profitability gauge for an asset-light fee business. ROE is net profit divided by average shareholders' equity. Net debt / EBITDA is total debt minus cash, divided by EBITDA — leverage measured against earnings power. Performance fees are the firm's share of fund profits above a hurdle return ("carried interest" in private equity language); they are episodic, not recurring.

---

1. Revenue, Margins, and Earnings Power

Investor question: how big is this business, and is its earnings power expanding, plateauing, or decaying?

Partners Group earns its money in two layers. Management fees (CHF 1,744m in 2025, ~68% of revenue) are charged on AUM and recur every year — they are the spine of the business. Performance fees (CHF 819m in 2025, ~32%) are paid when funds realize gains above their hurdles — they are lumpy, tied to the global exit environment, and have ranged from 18% to 36% of revenue across the last decade. Management's new disclosure (effective 2026 under IFRS 18) reframes these as "performance income" — the same economic concept — and guides the band to 25–40% of total revenue.

The shape is unmistakable: revenue compounded ~13% annually from 2010 to 2025, with a pronounced cycle peak in FY2021 (CHF 2.63bn — performance-fee bonanza after a 12-year private-equity cycle climaxed) and a trough in FY2022 (–29% YoY) when realizations collapsed. The recovery from 2023 onward is the new cycle: revenue is now back above the 2021 peak on a TTM basis, but the quality of that revenue is different — more management fees, less crystallized carry.

The margin line is the punchline of the business model. Operating margins have never been below 56% in 16 years and have stabilized in a 60–65% band. EBITDA margins have held near 63% for five years running — exactly what management points to as steady-state. The slight drift down in net margin (from 65% in 2014 to 49% in 2025) reflects two real effects: (a) higher effective tax rate (3.7% in 2005 → 17.7% in 2025, as Switzerland tax reform plus expansion into higher-tax jurisdictions bit in), and (b) interest expense rising as the firm took on senior notes between 2017 and 2024.

Recent semi-annual trajectory

Partners Group reports half-yearly. The picture across the last six halves shows the FY2025 reacceleration clearly.

H2 2025 revenue of CHF 1.40bn is a record half — up 20% on H2 2024 — and operating income +20% half-on-half. That tells you the cycle is in expansion, not exhaustion. The headline that matters: 2025 EBITDA grew +12% at constant currency but only +7% reported, after Swiss-franc strength versus the dollar, which is a recurring tax on a Swiss-listed company that books most of its fees in dollars and euros. It is not a margin problem; it is an FX translation problem.

---

2. Cash Flow and Earnings Quality

Investor question: are reported earnings turning into real cash, or is accrual accounting flattering the picture?

For a private-markets manager, the gap between net income and cash flow is where most accounting risk lives. Performance fees are recognized over time as funds mature (a contract-asset sits on the balance sheet) and are realized in cash only when underlying portfolio companies are sold. Receivables can build for years before crystallizing.

The chart shows the quality issue head-on. Across 16 years, cumulative net income (CHF 11.8bn) versus cumulative operating cash flow (CHF 10.4bn) is roughly 88¢ of cash per franc of earnings — solid but below 1.0×, which is the classic signature of a business where receivables grow faster than collections. Three years stand out as outliers: FY2013 (operating cash flow turned negative on a CHF 317m net income — performance receivables built up before realization), FY2018 (OCF only 37% of net income — same dynamic), and FY2021 (OCF 48% of net income — peak-cycle carry recognized but not yet collected).

The mirror of those gaps is the abundance years: FY2020, FY2022, and FY2025 all delivered OCF above net income because prior-vintage carry finally hit the bank account.

A 50% FCF margin is a stupendous number in absolute terms; a volatile 50% FCF margin is the working reality. The right way to think about it: average FCF margin across 2014–2025 is ~48%, and that is the number I would underwrite. Capex stays trivial — never more than 3% of revenue, just CHF 8.5m in 2025 versus CHF 2.56bn of revenue. There is essentially no factory to feed.

Receivables — where the next forensic question lives

Item	FY2020	FY2022	FY2024	FY2025
Revenue (CHF m)	1,412	1,872	2,136	2,563
Receivables (CHF m)	465	641	1,155	1,135
Receivables / revenue	33%	34%	54%	44%
Days sales outstanding (approx)	120	125	197	162

Receivables ballooned in 2024 to 54% of revenue (197 days) before partially normalizing in 2025 as cash collected against accrued performance fees. This is one of the items the short-seller report (Grizzly Research, April 2026) flagged. The forensic tab covers the merits in detail; for our purposes, the direction in 2025 is reassuring — receivables stopped growing in absolute terms and revenue accelerated, so the ratio is improving — but receivables remain the single most important earnings-quality line to watch each half.

---

3. Balance Sheet and Financial Resilience

Investor question: does the balance sheet give management room to act, or is it a constraint?

For a fee-and-carry manager the balance sheet is not the source of returns — it is a logistical asset that supports seed capital, GP commitments, and bridge financing for funds. So leverage should be modest and liquidity ample.

Net cash for nearly the entire decade. The shift from net cash to slight net debt of CHF 400m in 2025 reflects two senior-note issuances (2017 CHF 300m + 2019 CHF 500m) and an expanded short-term funding program. Even at peak debt the picture is benign:

Three things are worth flagging. First, interest coverage has fallen from 71× to 17× — still very strong, but the trend is clear: the firm is using debt as a permanent layer of the capital stack, not just a bridge. Second, the current ratio dropped sharply to 1.67× in 2025 as short-term debt expanded to CHF 1.06bn. Third, assets-to-equity has nearly tripled from 1.2× to 2.9× since 2015 — capital structure deliberately optimized to lift ROE.

The ratings agencies see it as fine: Moody's affirmed A3 investment grade in early 2026 and Fitch maintains an investment-grade rating. There is no realistic insolvency risk; the question is one of capital-allocation philosophy, not financial distress. With a 90% payout ratio (see next section), management has no plan to pay debt down — they intend to maintain modest investment-grade leverage in perpetuity.

---

4. Returns, Reinvestment, and Capital Allocation

Investor question: is management compounding shareholder value, or just running on the spot?

Returns on capital are extraordinary for any sector, let alone financials. ROE oscillates between 35% and 56% — averaged 43% over 12 years — and ROIC in the 35–77% band. The spread between ROE and ROIC has compressed as leverage has crept up; the operating return on capital has been remarkably stable at 35–45%. This is the financial signature of a moat: a recurring fee stream on USD 185bn of AUM that does not require commensurate balance-sheet investment.

Capital allocation — almost everything goes back to shareholders

The pattern across eight years is unambiguous: dividends are the dominant return, buybacks supplement, capex is rounding error, M&A is occasional and small. Cumulative across 2018–2025: CHF 6.4bn dividends + CHF 3.1bn buybacks + CHF 109m M&A + CHF 0.5bn capex.

The proposed FY2025 dividend is CHF 46.00 per share (paid out of FY2025 earnings of CHF 48.45 — a ~95% payout). The firm has paid an unbroken, growing dividend since 2008. The trade-off worth naming: the high payout means the firm is not compounding capital internally — book value per share has only edged up because most earnings leave the building. For an asset-light fee compounder this is the textbook-correct policy, but it means investor returns come almost entirely from price appreciation + yield, not from book-value growth.

EPS compounded ~13% per year over 2015–2025 despite share count moving ~1% lower. Book value per share is essentially flat over the same window (CHF 46 → CHF 84) because nearly all earnings are dividended out. The buyback yield averaged ~1% — not aggressive, more about offsetting share-based comp than return-of-capital ambition.

---

5. Segment and Unit Economics

Partners Group does not break revenue into reportable accounting segments, but management discloses AUM splits at the asset-class and structure level. Together with the performance-fee disclosure they revealed in the FY2025 results, this is enough to see where the economics live.

Private equity is 46% of the asset mix and produced 59% of the CHF 819m of FY2025 performance fees. Infrastructure is the secondary growth engine — 19% of AUM, 27% of performance fees, and the fastest-growing strategy at 18% AUM CAGR. Private credit is the new engine: 22% of AUM, 22% AUM growth, but only 13% of carry yet because credit funds carry lower hurdles and longer crystallization timelines.

By client structure: 67% of AUM is in bespoke separate accounts (mandates) — the highest-quality, longest-duration revenue line because mandates rarely churn. 30% is in evergreens/semiliquid funds, the new growth wedge. Only 3% is left in legacy traditional closed-end programs.

By geography (fundraising in 2025): North America 23%, Germany & Austria 18%, Switzerland 12%, UK 10%, Japan 7%, rest of world ~30%. The mix is unusually diversified for a Swiss-domiciled GP — North American LP demand has actually grown over the decade.

The unit economics are best summarized by management's own slide language: a 1.24% management-fee margin on average AUM during 2025 — and management explicitly guides that margin will be lower in 2026 because the mix is shifting toward larger, fee-discounted bespoke mandates and toward credit (which charges a thinner fee than PE). This is the most concrete piece of forward guidance in the FY2025 results, and it is the negative element that the market has priced in.

---

6. Valuation and Market Expectations

Investor question: what does the current price assume — and is that assumption defensible?

The right valuation lens for a fee-and-carry manager is P/E for steady-state, EV/EBITDA for cycle-adjusted, and dividend yield for income — not P/B or P/Sales, which are inappropriate for asset-light businesses. The whole stack is below decade norms.

The de-rating is real and severe. From the 2020-2021 peak (34× P/E, 29× EV/EBITDA) the multiple has compressed by 40–45%, and the dividend yield is at a 10-year high of 4.3%. Three things drove the de-rating: rising rates pulling all duration assets down (2022), the FY2024 receivables build prompting earnings-quality questions, and the April-2026 short-seller report on evergreen-fund valuation marks plus management's "lower management-fee margin in 2026" guidance, which together drove a multi-month drawdown of roughly 37% from late-2024 highs (~CHF 1,300) into the FY2025 results day on 10 March 2026 (CHF 818 close).

Bear / base / bull frame

Scenario	Assumption	FY27 EPS	Multiple	Price (CHF)
Bear	Performance fees fall to 18% of revenue (lower end of guidance), management-fee margin compresses 15bp, P/E re-rates to 14× on quality concerns	50	14×	~700
Base	Performance income lands inside 25–40% guidance, AUM compounds 8%, P/E recovers to 22× (10-year median)	65	22×	~1,430
Bull	Cycle reaccelerates, performance income tops 35%, AUM grows 12%, P/E re-rates to 26× on alignment with peers	80	26×	~2,080

Management's own forward guidance from the FY2025 deck is USD 65 EPS in FY2026 and USD 78.77 EPS in FY2027 — equivalent to roughly CHF 51–52 and CHF 62–63 at current FX. Guidance is therefore close to my "base" path but gives no benefit-of-the-doubt on multiple expansion.

---

7. Peer Financial Comparison

Native-currency market caps shown — direct cross-reading of multiples is apples-to-apples since multiples are unitless.

The peer table tells a clean story. PGHN posts higher EBITDA margins (63%) and the highest ROE (55%) in the group, with leverage (0.3× ND/EBITDA) far below APO (1.1×), BX (1.5×), KKR (62×, distorted by reinsurance accounting), and ARES (11×). EQT is the cleanest direct comparable — same European pure-play structure, smaller AUM. PGHN trades at a P/E half of EQT's, less than half of KKR's and BX's, and 25% below APO's, despite superior margins and returns. The peer-relative discount is the mechanical opportunity in the stock.

The legitimate counter-argument: US-listed alternatives are being valued for their insurance/permanent-capital franchises (APO/Athene, KKR/Global Atlantic, BX/wealth platform) — high-multiple growth engines PGHN does not yet have. PGHN's evergreen and semiliquid product line is the analog (USD 56bn of AUM in 2025, ~30% of total) but it is not yet a balance-sheet permanent-capital play. The discount is therefore partly explained by strategy mix; it is not entirely an irrational gap. But "partly explained" leaves significant room for the gap to compress if private-markets fundraising holds up.

---

8. What to Watch in the Financials

Metric	Why it matters	Latest (FY2025)	Better	Worse	Where to check
Performance income / total revenue	Tests whether new IFRS 18 disclosure stays inside 25–40% guided band	32%	35–40%	under 25%	Half-year results
Management-fee margin (% AUM)	Direct read on competitive pricing pressure on the recurring revenue base	1.24%	≥1.24%	under 1.10%	H1/H2 release
AUM net inflows (USD)	Volume engine for management fees	+USD 27bn raised	over USD 30bn	under USD 20bn	Fundraising update
Receivables / revenue	Gauge of accrual vs cash quality on performance fees	44%	under 40%	over 55%	Balance sheet
OCF / Net Income (TTM)	Cash conversion sanity check	1.20×	over 1.0×	under 0.7×	Cash-flow statement
Net debt / EBITDA	Resilience and capital flexibility	0.30×	under 0.50×	over 1.0×	Balance sheet
Dividend cover (EPS / DPS)	Tests sustainability of the high payout	1.05×	over 1.10×	under 1.00×	AGM proposal
ROIC	Compounding test on the asset-light model	35%	over 40%	under 30%	Return ratios
EBITDA margin	Operating-leverage signal	62.8%	≥63%	under 58%	Income statement
Forward P/E (consensus)	Re-rating tracker	~17×	over 22×	under 14×	Consensus screens

What the financials confirm. A high-margin, asset-light, high-ROE compounder with a clean balance sheet, a 17-year dividend track record, and a recurring-fee spine that has compounded through every cycle — exactly the financial signature you would expect from a moated franchise.

What the financials contradict. The neat "compounding machine" narrative is dented by performance-fee volatility, by the receivables build that climaxed in FY2024, and by the new admission that 2026 management-fee margin will fall — small cracks, but visible ones.

What is implied but not yet proven. Management's FY2026 EPS guide of USD 65 and FY2027 of USD 78.77 (~25% EPS CAGR over two years) requires both a continued exit cycle and AUM growth — neither alone is sufficient. The market is currently pricing as if at least one of those will fail.

The first financial metric to watch is the H1 2026 performance-income disclosure. If it lands inside the 25–40% guidance band, the cash-flow story re-asserts itself; if it slips below 25% on a cyclical exit slowdown, the bear case (CHF 700-area) becomes the relevant scenario.

Web Research

The Bottom Line from the Web

On 29 April 2026, US short seller Grizzly Research published a detailed report alleging that Partners Group materially overstates valuation marks in its evergreen funds — including its flagship Master Fund — calling the situation "worse than Wirecard." The company issued a same-day rebuttal on 30 April 2026, denouncing the publication as defamatory, weighing legal action, and referring potential market manipulation to regulators. Layered on top, an unrelated Bloomberg/SwissInfo interview (30 March 2026) revealed that CEO David Layton will transition out of the role within two to three years — a planned succession that the filings did not surface.

What Matters Most

1. Grizzly Research short report alleges valuation overmarking in evergreen funds

2. Company rebuts, weighs legal action, refers to regulators

3. Heavy net insider buying into the dip

4. CEO David Layton to transition in 2–3 years

5. Performance-fee pull-forward into 2025 will mute 2026

6. AUM hit USD 185B; 2026 guidance USD 26–32B in gross fundraising

PG raised USD 30B in 2025 versus its USD 26–31B guidance band, lifting AuM from USD 152B to USD 185B. 2026 fundraising guidance is USD 26–32B; tail-down effects from maturing closed-ended funds are estimated at USD 10–13B. Long-term target unchanged at USD 450B by 2033. Source: partnersgroup.com press release.

7. PG Chair flags doubling of private-credit defaults

8. USD 9B secondaries fund close — record investor demand

17 Apr 2026 — PG closed its 8th private equity secondaries program with over USD 9B of total commitments, the largest ever for the firm and a clear data point against the Grizzly narrative on weakening institutional demand. Source: finanzwire.com.

9. Stock down 21% over 12 months despite revenue beat

The shares are now within the 52-week low band (CHF 776–1,205), trading at roughly 18.2x trailing P/E with a 5.2% dividend yield. Q4 2025 results saw the stock plunge despite a revenue beat, reflecting the 2026 performance-fee step-down rather than weak operations. Source: Barron's, marketscreener.com.

10. Analyst tape is mixed; Deutsche Bank just cut

Average target CHF 1,158 across 16 analysts (range CHF 930–1,375) — implying ~32% upside from current. Deutsche Bank lowered its target to CHF 1,100 on 6 May 2026. Kepler Cheuvreux and Barclays each have Buy ratings (April 2026). Sadif Investment Analytics flipped from Sell (Sep 2025) to Hold (Mar 2026). Source: TradingView, TipRanks, marketscreener.com.

Recent News Timeline

The news flow tells two stories: an operationally strong 2025 (record fundraising, USD 9B secondaries close, AlphaValue calling realizations "excellent") and a confidence-shaking April that combined the Grizzly short attack with a confirmed CEO succession glide-path and a sector-level credit warning from the chairman.

What the Specialists Asked

Governance and People Signals

Founder ownership concentration. Glassdoor commentary describes "less than 20 people — including former and retired partners — own more than 40% of the outstanding share capital." Public float reported at 84.88% YE2024, implying roughly 15% closely held. Source: matrixbcg.com, Glassdoor reviews.

ISS QualityScore. Overall 4 (decile rank, 1=best, 10=worst) per Yahoo. Worst sub-pillar is Shareholder Rights at 9, suggesting governance frictions for minority holders — likely tied to the founder-block voting structure typical of Swiss listings. Source: Yahoo Finance PGHN.SW.

Board composition. Independent directors include Urban Angehrn (former FINMA CEO), Anne Lester, Gaelle Olivier, Flora Zhao. Founder/executive directors: Meister, Erni, Gantner, Wietlisbach. Source: Reuters PGHN.S.

Insider buying summary.

A net insider purchase of CHF 30.9M into a 13.1% drawdown is a constructive counter-signal to the Grizzly thesis — though it predates the 29 April publication and does not address the specific valuation allegations. Transaction-level breakdown was paywalled in the source. Source: insiderscreener.com.

Glassdoor caveats. Anonymous reviews allege high turnover, low compensation outside the partner ranks, and centralized founder economics. Treat as sentiment colour, not as audited evidence. Source: Glassdoor PGHN reviews.

Industry Context

Private markets industry projected to more than double by 2033. Per PG's CMD framing (cited by Reuters), the industry will roughly double by 2033 with PG targeting USD 450B AuM versus USD 185B today — implying a sustained low-teens AuM CAGR. The industry is consolidating around the largest sponsors as smaller real-estate and private-credit managers stagnate. Source: Reuters.

Evergreen / private wealth is the structural shift. By YE2024, ~32% of PG AuM (USD 48B) was in evergreen programs; H1 2025 evergreens delivered 35% of new assets. The Master Fund, launched 2009 as the first SEC-regulated private-markets fund, has compounded at ~11% per annum without a single down year per company disclosure. The Grizzly thesis explicitly attacks this revenue category. Sources: pestel-analysis.com, investing.com transcript.

Private credit cycle warning. PG's own chairman flagged that default rates could double from the decade-average 2.6% baseline. Whether this is sponsor talking-up-the-distress (to justify higher pricing on new vintages) or a genuine cycle-call is unresolved — but it is a sector-level data point being delivered by a top-tier participant. Source: Reuters/FT.

Listed-PE peer rerating. Per MarketScreener sector tables, EQT AB +11% over 1 year; PGHN -19.7%; CVC Capital Partners -16.1%; Bridgepoint -4.3%. The European listed-PE complex has been a relative underperformer; PGHN sits near the bottom of the cohort, indicating company-specific concerns are over-laid on a sector derate. Source: marketscreener.com.

PGHN underperforms even European listed-PE peers materially over 1Y — reinforcing that the discount is more company-specific (succession, performance-fee comp, short attack) than sector-driven.

Where We Disagree With the Market

The market is debating the wrong margin. Consensus has anchored on the 1.18-1.33% management-fee-rate band and concluded the moat is intact because the band held in 2025; our reading of the FY25 disclosure is that the management-fee EBITDA margin — the cleaner durable-economics gauge — compressed roughly 110 basis points year-on-year and was masked by a pulled-forward performance-fee surge. Layered on top, the company's combative posture toward Grizzly Research (legal action, regulator referrals, a "defamatory" framing) is the textbook deviation from a reasoned-rebuttal playbook, and the FY25 PwC audit was already signed before the report — meaning the binding audit test is the FY26 cycle, which the market is treating as priced. Insider buying at 10:1 is a real signal, but it is the consensus signal — Hold-to-Buy sell-side and a CHF 1,158 average target on 16 covers already reflect it. The variant view is narrower and harder: the market is taking FY25 EPS at face value, anchoring to the FY27 guide for fair value, and treating the forensic dimension as resolved when the disclosure-architecture changes (dropped redemption KPI, IFRS 18 "performance income" relabel, management-fee-EBITDA carve-out) read as a deliberate smoothing setup rather than housekeeping. Three observable signals between H1 2026 (1 September) and the FY26 audit cycle decide whether we are right.

Variant Perception Scorecard

The score is moderate, not heroic. Variant strength of 62 reflects a real, dateable disagreement on the quality of FY25 earnings and on the disclosure posture — not a cheap-stock thesis. Consensus is unusually clear because 16 covers, an average target of CHF 1,158, and a 10-year-low multiple all point in the same direction. Evidence strength is held back by the fact that the load-bearing claim — that management-fee EBITDA margin compression is structural, not mix-noise — turns on a single half-year disclosure cycle that has not yet printed. The first decisive signal lands in roughly four months on 1 September 2026; full resolution requires the FY26 PwC audit cycle ten to twelve months out.

Consensus Map

The map is unusually clean for a name in active drawdown. The de-rating priced cyclical fear (FY26 fee guide-down, perf-fee mean-reversion, evergreen redemption stress); it did not price a forensic-quality reset. Sell-side targets sit ~32% above spot, the dividend yield is a "10-year high" for a reason that consensus reads as opportunity, and the load-bearing assumption inside every constructive note is that FY25 EPS is a reasonable denominator. Three of the five consensus reads turn on that single anchor.

The Disagreement Ledger

Disagreement #1 — the wrong margin. Consensus would say group EBITDA margin held at 62.8% for the seventh straight year and the management-fee rate stayed inside its 20-year 1.18-1.33% band; ergo the durable engine is unimpaired. The forensic tab discloses Mgmt Fee EBITDA at CHF 1,090m FY25 vs CHF 1,033m FY24 — a +5.5% growth rate against management-fee revenue growth of +7.3% — which mathematically requires the management-fee EBITDA margin to have compressed from roughly 63.6% to 62.5%. That decoupling is hidden inside a headline that combined a +60% perf-fee surge with a quietly compressing FRE engine. If we are right, the consensus 22x re-rating thesis on FY27 guide overstates fair value because the FRE base it anchors on is shrinking on a unit-economics basis. The cleanest disconfirming print is an H1 2026 reading showing Mgmt Fee EBITDA margin recovering above 64% — a number the carve-out makes directly observable.

Disagreement #2 — smoothing, not housekeeping. The market accepts management's framing that the FY26 guide-down is one-off pull-forward of FY26 carry into FY25. The harder question is why the disclosure architecture is being widened simultaneously. In a 24-month window: a Management Fee EBITDA carve-out was introduced; the redemption inflow/outflow KPI was dropped; "performance income" combines perf fees with investment income; group-level EBITDA replaced EBIT as the headline. The forensic tab grades B6 (income smoothing) and D1 (showcase metrics) Yellow precisely because the EBITDA margin band of 62.6-64.3% across five years is mechanically held by the matched 50% NAV stress and 40% perf-fee comp absorber. If the variant is right, the bull case's "trough EPS at 14x = CHF 700" and "base EPS at 22x = CHF 1,430" are both anchored on a denominator that management is preparing to widen; the disconfirming print is an H1 2026 release that re-disclosed redemption flow data and split investment income out of the new performance-income bucket.

Disagreement #3 — combative posture as a tail-risk signal. The standard alternative-asset-manager response to a valuation short-attack is a reasoned, asset-by-asset rebuttal with independent third-party valuation references — see Blackstone's BREIT defenses 2022-2024. PGHN's response to Grizzly opted for legal action and a regulator referral against the publisher, framed as "defamatory" and "market manipulation," and did not release the third-party valuation methodology on the named positions. The PwC FY25 audit was already signed clean before the 29 April 2026 publication — an irrelevant disconfirmation of allegations that did not yet exist. The unpriced binary is the FY26 audit cycle, which is the first PwC opinion on these private fair values after public allegations and after the auditor handover at the May 2025 AGM. If we are right, a PwC emphasis-of-matter on private investment fair values at FY26 results in a binary regime change for both the FRE and the carry multiple; the market is pricing this probability at near-zero on the basis of the pre-Grizzly opinion.

Evidence That Changes the Odds

The variant view does not require the consensus to be wrong on every dimension; it requires the consensus anchor to be wrong. That anchor is FY25 EPS at face value combined with a "62.8% margin held seven straight years" durability narrative. The first three rows of the table directly attack the anchor. Row 5 is the cleanest single piece of evidence — by management's own admission, FY25 included carry that belongs to FY26, which means the trailing 20.3x P/E quoted as "10-year low" is an artifact of an inflated denominator. The market has not redrawn the multiple chart on adjusted EPS. Row 6 is the row a senior analyst should reread carefully: the insider-buying signal is real but it is in the consensus already, and a defensive-buying interpretation is consistent with the disagreements above. The table is meant to be audited, not believed.

How This Gets Resolved

The first three rows are dateable and observable. Signal #1 (Mgmt Fee EBITDA margin) prints in 16 weeks and is the cleanest single test — a number the company itself surfaced in FY24 and that management cannot easily redefine without inviting more scrutiny. Signal #2 (disclosure architecture) is a behavioural test that resolves on the same date: either redemption KPIs return and performance income splits cleanly, or they don't, and the smoothing-regime read tightens. Signal #3 (PwC FY26 opinion) is a slower binary that lands in early 2027 but defines the asymmetry — emphasis-of-matter is a low-probability event that is being priced at near-zero today, not at a low-but-nonzero level. None of the three demands a forecast; all three demand attention to a specific line of disclosure.

What Would Make Us Wrong

The cleanest way the variant breaks is that the FY24 → FY25 Mgmt Fee EBITDA decoupling we are flagging turns out to be Empira-integration noise. The Empira (real estate) acquisition closed early 2025 and added USD 4bn of AuM in H1 with consolidation through the year; integration cost lines, transaction-related accruals, and one-time amortisation could easily explain a 110bp band-of-error on a CHF 1,090m number. If the H1 2026 print shows Mgmt Fee EBITDA margin snapping back above 64% — and management explicitly attributes the FY25 reading to Empira-related cost layers — Disagreement #1 collapses and the rest of the ledger weakens. We have no way to falsify this from current disclosure; the H1 2026 reading is the test.

The smoothing-regime disagreement has a cleaner refutation path. If the H1 2026 release re-introduces the evergreen redemption inflow/outflow KPI, splits performance income into perf-fee and investment-income components, and disclosure quality net improves, the disagreement closes hard. The disclosure-architecture changes are reversible; if they reverse on the next print, our read was over-engineered. The forensic tab itself grades B6 (income smoothing) Yellow with Medium confidence, not Red — appropriate humility from the upstream work, and we should not exceed it.

The Grizzly-response disagreement is the weakest of the three on its own merits. PGHN may simply be a more litigious culture than its US-listed peers without that culture encoding any underlying mark issue; insider buying 10:1 by founders who own 15.1% direct is a real counter-signal even if it is widely known. A clean PwC FY26 opinion with no emphasis-of-matter on private investment fair values, paired with at least one independent realised exit on a named position at-or-above book value, refutes the disagreement decisively. We should size for the asymmetry — emphasis-of-matter is binary regime change, not gradual erosion — but we should also accept the base case is a clean opinion.

Finally, the "FY25 EPS overstates run-rate" claim has a straightforward kill: management quantifies the pull-forward at less than 5% of EPS, the H1 2026 print confirms a recovery in run-rate carry, and consensus targets are revised toward CHF 1,200+ on FY27 visibility. In that path, the multiple anchor consensus is using is honest and the de-rating closes mechanically. The variant view does not require the bear case to play out; it requires the consensus anchor to wobble. If the anchor holds, we are wrong.

The first thing to watch is the management-fee EBITDA margin reading in the H1 2026 results on 1 September 2026 — a number the company itself disclosed in FY24, that consensus does not yet anchor to, and that decisively confirms or refutes the highest-conviction disagreement in this tab.

Liquidity & Technical

PGHN trades CHF 85M of value per day (under 0.4% of market cap) with 100% session coverage and a sub-1% median daily range — institutionally tradeable, but capacity-constrained: any issuer-level position above roughly 0.4% of market cap takes more than five trading days to enter or exit at 20% ADV. The tape itself is bearish: price sits roughly 10% below the 200-day moving average with the 50-day in death-cross territory since April 2025, the stock is at the 23rd percentile of its 52-week range, and the recent bounce off the lows is being capped by elevated realized volatility (29%, p70 of the 5-year band).

1. Portfolio implementation verdict

2. Price snapshot

Beta is omitted: the standard CH broad-market series was not available for this run, so a fitted beta would be cosmetic. Realized vol substitutes as the cleanest single risk metric.

3. Price vs 50/200-day moving averages — full history

Price is below the 200-day moving average (close 879.2 vs SMA200 980.28, gap −10.3%) and only marginally above the 50-day (857.15). The full-decade view shows a single secular uptrend from 2016 to mid-2021 (peak CHF 1,658), a 50%+ drawdown into mid-2022, a partial round-trip into 2024, and now a renewed leg lower since the April 2025 break — current price has unwound almost three years of gains. This is a downtrend regime, not a base.

4. Relative strength vs benchmark

Broad-market and sector benchmark series were not staged for this Swiss-listed ticker (the run's relative-performance file has the company series rebased but no comparator). Rather than fabricate a comparison line we'll note the absolute facts: PGHN is −20% over the trailing year and −32% over five years, while diversified European financials and listed alternative-asset managers as a group have generally been positive over both windows. Read this as material relative underperformance and treat the next anchor (volume / sponsorship) as the substitute for a relative-strength chart.

5. Momentum — RSI(14) and MACD histogram

RSI sits at 49 — neutral on the surface but the structure is informative: every push to 70+ (Jan-25, Jul-25, Apr-26) has been followed by a sharp roll-over within four weeks, while the November-25 RSI low at 28 marked the price low. The MACD histogram has cycled three times in 18 months and is currently rolling negative again from a +13 peak in mid-April; that's a near-term sell signal until the histogram crosses back above zero. Net momentum read: failed rally, not new uptrend.

6. Volume, volatility, and sponsorship

The 50-day average has stair-stepped from roughly 45k shares/day in late August 2025 to over 130k in late April 2026 — volume is migrating into the downtrend, which usually marks distribution rather than accumulation. The structural lift in turnover is itself a sponsorship signal: big holders are repositioning, not adding.

Four of the five largest volume events in the last six years closed flat or sharply lower; the lone exception (May-21) was during the 2021 melt-up and only printed +0.2%. This is not a tape that spikes on good news — it spikes on selling.

Realized vol at 29% sits at roughly the 70th percentile of the 5-year band — elevated, not stressed. Combined with the stair-step in volume, this says the market is demanding a wider risk premium without yet panicking; consistent with a tape that is still discovering its low rather than rebasing higher.

7. Institutional liquidity panel

A. ADV and turnover

ADV 60d (123k shares) running 28% above ADV 20d (96k) confirms the stair-step pattern visible in the volume chart — turnover is elevated against trend.

B. Fund-capacity table

Read across: at 20% ADV participation, this name absorbs CHF 84.5M (~USD 109M) over five trading days — supporting a 5%-weight position in funds up to CHF 1.7B (~USD 2.2B), or a 2%-weight position in funds up to CHF 4.2B (~USD 5.4B). Halve the participation rate and you halve the supported AUM.

C. Liquidation runway

D. Execution friction

Median 60-day daily range is 0.98% — tight, well under the 2% threshold where impact cost becomes a meaningful drag. Zero zero-volume sessions, 100% session coverage. Bid-ask cost is not the bottleneck; participation rate is.

Bottom line on capacity: at 20% ADV the largest issuer-level position that clears in five trading days is roughly 0.4% of market cap (CHF 90M / USD 116M); at 10% ADV that halves. A 1% issuer position takes 14 trading sessions to enter or exit at the more aggressive participation rate. PGHN is sized-position country, not "throw a 5% portfolio weight at it on day one" country.

8. Technical scorecard and stance

Stance — bearish on a 3-to-6 month horizon. Total scorecard score is −4 of a possible −6. The setup is a classic post-distribution downtrend: price below a falling 200d, momentum failing on each push to the upper bound, volume confirming the down moves, and realized vol elevated. The only constructive read is that the stock is closer to its 52-week low than its high — which is a bounce setup, not a turn. The two levels that change the view: (1) a daily close above CHF 985 (the 200-day SMA) reclaims the trend and forces a re-mark to neutral; (2) a daily close below CHF 785 (the 52-week low) confirms the next leg lower and turns the stance to outright avoid. Liquidity is not the binding constraint — the tape is. Funds that want exposure should watchlist for one of those two breaks rather than chase here; size any pilot position at sub-0.5% issuer weight so the implementation timeline stays inside two trading weeks at 20% ADV.